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ABSTRACT
DOWN-REGULATION OF NATURAL KILLER CELL ACTIVATION IN RESPONSE
TO INFLUENZA VIRUS IN OLDER ADULTS

Yu Jing
Eastern Virginia Medical School and Old Dominion University, 2007
Director: Dr. Yuping Deng
Co-director: Dr. Stefan Gravenstein

Immune senescence contributes to influenza-associated high mortality and morbidity
and reduced vaccine efficacy in elderly people. Type I T cell (Thl)-m ediated immunity
plays a significant role in Immune responses to influenza infection and vaccination.
Natural killer (NK) cells secrete significant amount o f IFN-7 , a hallmark T hl cytokine, in
response to influenza infection. How aging influences human NK cell IFN - 7 production
in response to influenza virus has not been well documented. In this study we employed
human peripheral blood mononuclear cells (PBMC) and performed intracellular cytokine
staining and flow cytometry primarily to investigate how aging influences NK cell
activation with respect to IFN - 7 production in response to influenza virus. We have
found that NK cell IFN - 7 production, mediated by both soluble factors and cell-cell
contact factors is down-regulated in elderly subjects compared to young subjects in
response to influenza virus. As for soluble factors, IFN-o: and IFN - 7 are proven to be
important in inducing NK cell to produce IFN-7 . The frequencies o f IFN-a-producing
plasmacytoid dendritic cells (pDC) and IFN-7 -producing T cells in PBMC are lower in
the elderly subjects than in the young subjects. Further more, pDC from the young
subjects produce more IFN-o: on a per-cell basis and mediate NK cells to produce more

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

IFN-y than pDC from the elderly subjects. As for cell-cell contact factors, the
expressions o f NKp44 and NKp46, two natural cytotoxicity receptors on NK cell surface
specifically recognizing influenza hemagglutinin (HA) expressed on antigen presenting
cells, are up-regulated upon influenza infection o f PBMC, but display higher expression
levels in older subjects than young subjects. Our data have demonstrated that agingrelated numerical and/or functional impairment in pDC and T cells results in lower
production o f IFN-o; and IFN-y, and consequently contributes to the down-regulation o f
IFN-y production in NK cells in response to influenza virus in older adults. How aging
affects NK cell IFN-y production through influencing cell-cell contact regulation between
NK cells and antigen presenting cells remains to be elusive. It’s our strong belief that our
study and the related findings will help enrich our knowledge about how aging affects
innate as well as adaptive immune system in response to influenza virus, and help build
the fundamentals for developing more effective prophylactic and therapeutic approaches
to fulfill the long-term goal o f reducing influenza morbidity and mortality and improving
the quality o f life for the elderly.
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I. INTRODUCTION

Influenza virus is highly contagious and among those pathogens with greatest potential to
cause life-threatening epidemic and pandemic outbreaks (1). Influenza-related morbidity
and mortality increase with age, particularly in people over 65 years old, making
influenza and its most common complication, pneumonia among the top 5 leading causes
o f death for this age group (2, 3). Vaccination can effectively prevent the occurrence and
severity o f the disease (2, 4, 5). However, the vaccine efficacy is significantly lower in
old people than in their young counterparts (3, 4, 6-12). The cause for the age-related
increase in mortality and morbidity and reduction in vaccine efficacy is related to
immune senescence (3, 4, 13). Investigations on how the immune responses to influenza
virus are impaired in older adults will provide the fundamental for developing more
effective prophylactic and therapeutic approaches for older people. Natural killer (NK)
cells are the major lymphocytes in innate immune system and play a significant role in
influenza-induced host defense by eliciting cytotoxicity and secreting IFN-y (14). How
aging influences NK cell activation, particularly with respect to their function o f IFN-y
production in response to influenza virus has not been well documented. The overall
objective o f this study is to investigate the age-related changes and their potential causal
factors in NK cell activation determined as the frequency o f IFN-y producing NK cells in
response to influenza virus in older subjects.

1.1 Overview o f Influenza Virus

Influenza viruses are members o f the family o f orthomyxoviridae with single stranded,
negative sensed segmented RNA genome. Based on antigenic differences in viral nuclear
protein (NP), influenza viruses are classified into A, B and C three types (15). Influenza
A and B are the two types known to be associated with diseases in human and animal
(15).

The journal model for this dissertation is Journal o f Immunology.
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Epidemiology o f influenza in humans

Influenza is a serious public health problem. According to Center for Disease Control,
each year in the United States, 5% to 20% o f the population gets influenza, over 200,000
people are hospitalized, and about 36,000 people die from influenza (16-19). Influenza is
associated with high morbidity (over 50%) and mortality in people 65 years and older
(over 70%). The high morbidity rate is also found in children less than one year old (as
high as 70%) (1, 20). Majority o f influenza occurs between late fall and early spring,
indicating influenza is a seasonal disease (2 1 ).

Influenza viruses continuously undergo antigenic variation by two means: antigenic drift
and shift (1). Antigenic drift involves minor changes in the envelope glycoproteins
hemagglutinin (HA) and neuraminidase (NA) due to mutation, deletion or other changes
in genes encoding these proteins during viral replication. Antigenic shift involves major
changes in these molecules resulted from reassortment o f viral genomic segments when
more than one strain o f influenza virus co-infect a host cell (1, 22). According to the
antigenic diversity o f HA and NA, there have been identified 16 HA subtypes and 9 NA
subtypes o f influenza A viruses (23). Changes in antigenecity o f HA and NA allow
influenza viruses to evade from host immunity and significantly increases the chance for
infection ( 1).

Influenza virus is associated pandemic outbreak (24). Important influenza pandemic
outbreaks in human history documented since 1889 include those in 1889 (H2N?), 1899
(H3N8), 1918 (H1N1), 1957 (H2N2), 1968 (H3N2) and 1977 (H1N1) (25). Three
explanations have been addressed for the formation o f a pandemic strain (1). Antigenic
shift could facilitate generation o f a new high-virulence strain. Direct transfer o f a highvirulence avian strain to human could occur or a human strain that caused an epidemic
many years ago could re-emerge (1, 26). Direct transfer o f a high-virulence strain from
avian animals to human has been confirmed by the influenza epidemics that took place in
Hong Kong during 1997-1998 (27). Influenza transmission is through the aerosol route.
Avian and domestic animals are the important hosts and reservoirs o f influenza viruses
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(1). Close contact with these animals may increase the chance for co-infection as well as
direct transmission ( 1 , 28).

•

Replication o f influenza virus

Influenza A genome contains 8 negative sensed RNA segments encoding for 10 proteins:
polymerase B2 (PB2), PB1, polymerase A (PA), hemaglutinin (HA), NP, neuraminidase
(NA), matrix proteins 1 and 2 (M l and M2), and non-structural proteins 1 and 2 (NS1
and NS2) (15). The HA residing on the viral envelope mediates attachment o f the virus
to target cell via binding to sialic acid residues on glycoproteins o f host cell membrane
(29). After binding, influenza virion enters the cell by endocytosis and arrives in acidic
endosome, where HA is cleaved and M2 ion channel is activated. Establishment o f
acidic environment in the virion induces alteration in M l/R N P and M l/H A interactions
and conformational change in the HA, consequently activating fusion o f viral envelope
and endosomal membrane (15, 30). The nucleocapsid is released to the cytosol and
transferred to the nuclear, in which viral replication takes place. Making use o f m7G cap
from cellular mRNA, the three RNA polymerases PB2, PB1 and PA function in concord
to transcribe the viral genome into positive sense mRNA and cRNA, the former used for
protein translation and the latter used as the template for generating new viral genome.
Newly generated NP protein migrates to nuclear and associates with newly synthesized
vRNA to form nucleocapsid. The accumulation o f nucleocapsid in cytosol initiates the
assembly (31, 32). Being facilitated by NA protein, the assembled virions are released
from the cell via budding process and spread to other cells (31, 33).
•

Influenza viral-host interaction

Like many other viruses, influenza virus encodes proteins that interact with cellular
components and counteract the host anti-viral activity in favor o f its own replication.
Influenza NS1 protein can modulate viral RNA transcription and replication, and inhibit
nuclear export o f the host polyadenylated mRNA (34), mRNA splicing (35-37), and
apoptosis (38). Further more, it is a potent inhibitor for IFN-a production and IFN -a
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Figure 1. Replication o f influenza virus and therapeutic approaches. (Modified, original
figure from Microbiology @ Leicester: Virology: Orthomyxoviruses or http://wwwmicro.msb.le.ac.uk/3035/Orthomyxoviruses.html)
effector function (39). Particularly, NS1 has been known to be able to bind to dsRNA
and inhibit dsRNA-induced IFN-o: gene transcription (40, 41). It is also able to interfere
with 2-5(A) synthetase/RNaseL as well as PKR activation pathways (42-45) to inhibit
antiviral activity o f IFN-o:. A recent study has shown genes affected by N S 1 are not
restricted to IFN-o:. Those coding for human macrophage inflammatory protein lb
(M IPlb), interleukin-12 p35 (IL-12 p35), IL-23 p l9 , RANTES, IL- 8 , and CCR7 are
down-regulated by NS1, underlying NS1 may “specifically suppress DC maturation,
migration, and NK and T-cell stimulatory activity” (46). In addition to NS1, influenza
HA has been newly revealed to selectively suppress interleukin 12 p35 transcription in
murine bone marrow-derived dendritic cells (47). IL-12 production is under the
detectable level in human PBMC stimulated with influenza virus alone (48, 49). Whether
NS1 and/or HA protein significantly contribute to the cessation o f IL-12 production in
human PBMC remains unknown.
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Pathogenesis o f influenza virus

Influenza virus infects and exclusively replicates in epithelial cells o f the respiratory tract
and causes most significant pathology in the lower respiratory tract (1). Release o f viral
particles from the apical surface o f the cells restricts systemic spread o f the virus but
facilitates accumulation o f virus in the lumen o f the respiratory tract for transmission
through air ways (1). Local inflammation and edema are associated with infected tissues.
Ciliated epithelial cells can be vacuolated, lose their cilia and become desquamated. Viral
antigen can be detected in epithelial cells and mononuclear leukocytes. In the case o f
severe primary viral pneumonia, mononuclear leukocyte infiltration, capillary dilation
and thrombosis are predominant and viral antigens can be detected in type 1 and type 2
alveolar cells and macrophages (50). Influenza A and B can cause the same spectrum o f
diseases. Primary viral pneumonia, combined viral-bacterial pneumonia and bacterial
pneumonia following an influenza infection are three severe conditions associated with
influenza. Complications are most often in the elderly (1)
•

Treatment o f influenza

Influenza can be treated or prevented by chemical drugs specifically targeting M2 ion
channel (amantadine and rimantadine), NA protein (Zanamivir and Oseltamivir) or viral
RNA replication (ribavirin,(51, 52). Distinct from chemical drugs, influenza vaccination
has been proved to be the most cost-effective method in reduction o f influenza-related
mortality and morbidity (53, 54). Because o f the antigentic drift, the strains used for
generating the vaccine have to be determined every year. The vaccine contains three
influenza strains, one A (H3N2) strain, one A (H1N1) strain, and one B strain, each
representing one o f the three groups o f viruses circulating among people in a given year
(1, 55).
There are two types o f licensed vaccines. The first is the inactivated or split trivalent
influenza vaccine (TIV). It contains killed virus and are effective for both young and
elderly subjects. The TIV is highly recommended to people at high risk o f influenza,
including children 6-59 months, people 50 years and older, pregnant women and people
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with chronic medical conditions (16, 56). Though effective, the TIV efficacy is
significantly lower in elderly subjects than that in the young, making the elderly people
less effectively protected by the vaccination (3,12). Immune senescence is believed to
contribute to the low vaccine efficacy in the older adults (13). The second type o f
influenza vaccine is a live attenuated influenza vaccine (LAIV) or FluMist. FluMist is
recommended to healthy people between 5-49 years old and has been shown more
effective to stimulate immune responses in healthy young adults or even high-risk
subjects, such as children diagnosed with asthma than TIV (16, 57, 58).
1.2 Significance o f Influenza Virus in Aging

Influenza/pneumonia is the fifth leading cause o f death for people 65 years and older (59)
As recorded for the United States in year 2000, influenza/pneumonia claimed 60,261
lives aged 65 years and older, which constituted 0.173% o f the total population and 3.3%
o f elderly o f the same age range in the country (59). Influenza infection is associated
with high mortality and morbidity rates in the elderly. However, the vaccine efficacy is
significantly lower in older people than that in the young. The lower vaccine efficacy is
manifested by age-associated decline in intact humoral response to influenza vaccination
and low protective rate o f the vaccines. In particular, seroconversion, measured as fold
o f increments in sera antibody titer upon vaccination, and seroprotection, measured as
certain dilution factor o f the sera antibody, rates are significantly lower in older subjects
than those in the young ( 8 , 60). More over, in contrast to 70-90% protective rate in
young adults, there is only 30-40% o f influenza infection that can be prevented by
vaccination in the elderly (3, 8-11). W ith the unprecedented enlargement o f the body o f
aged population, it is believed influenza will have a significant impact on the quality o f
life for the elderly.

1.3 Overview o f Aging

Aging is defined as “a process that converts healthy adults into frail ones with diminished
reserves in most physiologic systems and an exponentially increasing vulnerability to
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most diseases and to death” (59). Aging has been viewed as a distinct variable from
diseases. Richard Miller has proposed that slowing-down o f aging alone will produce
longer life expectation than curing any individual or combinations o f the diseases that are
leading causes o f death for the elderly (Figure 2) (59, 61). According to R. Miller, a
question yet to be answered is “which age-related changes can be considered a part o f
normal aging”. A study to examine aging effect on a particular event by comparing
healthy young and “healthy” elderly subjects most time has to be in compliance with the
fact that elderly are rarely completely “disease-free” and any disease could be a potential
“confounding” factor for normal aging (59). On the other hand, if the elderly subjects
whose health status is strictly comparable to that o f their younger counterparts are used in
a study, how much these extremely healthy subjects would represent the typical elderly
population will be questionable.

just Like Today— average 50-year-old woman lives to 81
Cure Cancer Today
Cure H eart Disease Today
Cure Cancer and H eart Disease Today
Cure Cancer, Heart Disease, Stroke, and Diabetes Today
Slow Down Aging

40

50
60
Years o f Life Left at Age 50

70

80

Figure 2. Life expectancy at age o f 50 by disease categories. (Source: R.A. Miller/
University o f Michigan)
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•

Epidemiology o f aging

Aging o f human population has formed a global trend. The growing elderly population is
not only caused by “general increase in the overall population size” but also more
influenced by increased longevity o f older people accompanied by declining birth rate
following the birth boom in 1940’s and 1950’s (59). According to US Census Bureau,
actual or projected total US population are 76.1 million in 1900, 152.3 million in 1950,
276.1 million in 2000 and 403.7 million in 2050, with 4.1%, 8.2%, 12.6% and 20.3% in
each o f these years accordingly being people 65 years and older. In 1900, only 39% male
and 43% female could live till 65 years with average life expectancy o f 32-49 years. By
1997, the percentages have been increased to 77% for male and 8 6 % for female with
average life expectancy o f 67-80 years (59).

Aging is associated with greater mortality and morbidity. A wide range o f diseases such
as cancer, cardiovascular and neurodegenerative disorders have a significant agedependent onset (62). In 2000, heart diseases and cancer has claimed nearly one million
older lives in the United States, which accounts for over 50% o f total death in older
people in the year. For over two decades, heart diseases, sequentially followed by cancer,
stroke, chronic obstructive pulmonary diseases (COPD), pneumonia/influenza, diabetes
mellitus and Alzheimer’s diseases have been the leading causes o f death for people over
65 years o f age (59). W ith the rapid increase in the aging population, it is important for
us to gain better understanding about the aging mechanisms. This provides the
fundamentals for developing more effective prophylactic and therapeutic approaches for
diseases associated with advanced aging.

•

Biology o f aging

Aging, although not a disease, like many diseases is a genetically controlled,
environmentally influenced process. Studies on caloric restriction (CR) or a single gene
mutation that help produce long-lived animals in yeasts, nematodes, fruit flies and
rodents have evidenced close relationships between activation o f dafl 6 gene, lower level
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o f insulin and insulin-like growth factor 1 (IGF-1), increased DNA repairing ability and
postponement o f aging (59, 63, 64). Caloric restricted mice and Ames dw arf (AD) mice,
the latter carrying a mutation at Propl gene on chromosome 11 leading to their growth
retardation live 30-50% longer and share lower body temperature and lower level o f IGF1 than the control mice (59, 63). Single gene mutation in certain d a f or age genes that
has produced longevity in fruit fly Drosophila melanogaster and soil nematode
Caenorhabditis elegans is found to be associated with activation o f dafl 6 gene whose
regulatory factor da£2 is homologous to insulin and IGF-1 receptors in mammals (65, 6 6 ).
Long-lived yeasts and worms have shown stronger resistance to cellular damage caused
by ultraviolet, oxidizing agents and overheating and IGF-1 has been reported to play a
significant role in mediating DNA repair (59, 67). These evidences suggest the aging
process may be fundamentally related to cellular repair system.

1.4 Immunology o f Aging

Aging o f the immune system or immune senescence, leads to immune dysfunction.
Immune senescence has been proposed by Walford to account for three major causes o f
disease in old age: increased autoimmunity, higher occurrence o f cancer and increased
susceptibility to infectious diseases ( 6 , 6 8 ). Changes in both innate and adaptive
immune systems are found with aging.

•

Innate immune system in aging

In the innate immune system, TLRs are a family o f pattern recognition receptors binding
to pathogen-associated molecular patterns (PAMPs) and serve as a sentinel to induce
cytokine production (69, 70). TLRs are widely and differentially expressed in antigen
presenting cells as well as lymphocytes in human PBMC. Human and mouse studies
have indicated myeloid DC (mDC) and monocytes express TLR 1, 2, 4, 5, 6 and 10 either
at mRNA level or at protein level and mainly respond to bacterial stimuli by producing
TNF-alpha, IL -6 and IL-12. Plasmacytoid DC (pDC) preferentially express TLR7 and 9
proteins, which confers their ability to respond to viruses and CpG by producing large
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amount o f type I IFNs (71, 72). TNF-a, IL-12 and IFN -a are able to stimulate T hl cellmediated immune response while IL -6 is able to stimulate B cell development and
differentiation into plasma cells to produce antibody (73, 74). Characteristics o f
mammalian TLRs are summarized in Table I. Renshaw and colleagues reported the
expression o f TLR 1-9 in APC o f aged mice is down-regulated compared with young
mice. Consistently, declined TLR expressions contribute to less production o f cytokines
TNF-alpha and IL -6 in macrophages stimulated by TLR ligands (75), suggesting TLR
pathway is affected by aging process. Among cytokines and their producing cells, type I
IFNs and pDC have been drawn special attention and being investigated prosperously in
recent years (76-78). However, studies on their age-related changes are far from
sufficient even after pDC was identified as the most potent type IIF N producing cells
(79-81).

In the innate immune system, NK cells are the major type o f cells derived from lymphoid
lineage and represent 5-15% o f total human PBMC (82-84). Two distinct subtypes o f
N K cells can be identified based on their differential expressions o f cell surface antigen
CD56, and CD 16. CD56brightCD16dimNK cells preferentially secrete high levels o f IFN-y
and CD56bnghtCD16dimNK cells primarily execute cytotoxicity and secrete relatively
lower levels o f IFN-y upon activation (84, 85). It is known in human peripheral blood
N K cell frequency increases and their per-cell-based cytotoxic activity declines with age
(86-90). Details o f phenotypic and functional properties o f NK cells will be discussed in
session 1.6 .

•

Antigen presentation in aging

Dendritic cells, monocytes are the professional antigen presenting cells (APC) that link
the innate and adaptive immune systems. Dendritic cells, existing in peripheral blood at a
frequency o f less than 1%, include two major subsets, myeloid dendritic cells (mDC) and
plasmacytoid dendritic cells (pDC) (94). Resting human mDC expresses high level o f
CD 11c, an unconventional MHC class I-like molecule and low level o f CD 123, IL-3
receptor alpha chain. On the opposite, resting human pDC expresses high level o f

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

11
Table I. Characteristics o f mammalian Toll-like receptors (69, 72, 91-93)
TLRs

Dimerization

Location

Ligands

1

heterodimer
with TLR2

cell
surface

triacyl lipoprotein

2

heterodimer
with TLR1 or

cell
surface

bacterial
lipoprotein,
peptidoglycan; viral
glycoprotein;fungi
dsRNA
lipopolysaccharide
(LPS)

6

Humanrestriction
no

Expressing cell
macrophage,
monocytes,
mDC
macrophage,
monocytes,
mDC, T

no

3
4

homodimer
homodimer

cytoplasm
cell
surface

5

homodimer

cell
surface

falgellin

no

6

heterodimer
with TLR2

cell
surface

diacyl lipoprotein

no

7
9

homodimer
homodimer
homodimer

cytoplasm
cytoplasm
cytoplasm

no
no
no

10

unknown

unknown

ssRNA
ssRNA
non-methylated
CpG
unknown

no

macrophage,
epithelial cell

11

unknown

unknown

uropathogenic
bacteria, profilinlike protein in
protozoa

yes

mDC

8

no
no

NK, T
macrophage,
monocyte,
mDC
macrophage,
monocytes,
mDC, epithelial
cell, T
macrophage,
monocytes,
mDC, T
pDC, NK
NK, TREG
pDC, B, T

CD123 but no CD1 lc (95, 96). Monocytes comprise about 5-10% o f total human PBMC
and express cell surface marker CD 14, a co-receptor along with Toll-like receptor (TLR)
4 for bacterial lipopolysacchrides (97). Antigen presentation involves formation o f
complex o f endogenous or exogenous antigens to be presented with MHC class I or class
II molecules. The majority o f protein-derived antigens are short (8-11 amino acids)
peptides (98). Some o f these peptides are derived from newly generated proteins,
forming complexes with MHC class I molecules and presented to CD 8 + T cells. Others
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are derived from exogenous proteins, forming complexes with MHC class II molecules
and presented to CD4+ T cells or forming complexes with MHC class I molecules and
cross primed to CD 8 + T cells (98-101). In addition to peptides, new forms o f proteinoriginated antigens have been recently identified. These include the intact proteins and
the complexes formed by peptides and heat shock proteins, both being found to be
involved in MHC class II-restricted presentation and/or MHC class I-related cross
priming (99,102-105). Evidence has been shown that aged mice alveolar macrophages
are less efficient in antigen presentation than young cells, indicating antigen presentation
is potentially affected by aging (106,107).

•

Adaptive immune system in aging

Beyond the innate immune system, the adaptive immune system, in which T and B
lymphocytes are major cell types, is characterized with specificity, memory and tolerance
in eliciting immune responses. Although age-associated changes in the number o f total
peripheral T lymphocytes have not been convinced, numerous functional impairments in
T cells have been displayed with advanced aging. First, loss o f CD28 in aged T cells
significantly reduce T cell proliferative ability though expression o f the early activation
signals, such as CD69, is well preserved (108-111). Second, aged T cells are known to be
deficient o f calcium (112). Calcium is critical for many cellular events. Calcium
deficiency can lead to failure o f activation o f important enzymes, such as MAPK and
MEK involved in signal transduction pathways and consequently affect cytokine
production, cell proliferation, and cytotoxicity (113-116). Third, aging influences T cell
transcriptional factors directly. NF-kB and AP-1 have been found to be inactivated in
aged T cells (117). IL-2 is critical for T cell proliferation and able to stimulate NK cell
differentiation and activation (81, 118). Down-regulation o f IL-2 expression is largely
accounted for by the impairment o f transcriptional factors in aged T cells (119).

T cells are highly heterogeneous and aging influences the frequency and function o f
different T cell subtypes. Type 1 (T hl) and type 2 (Th2) T helper cells are the two major
subtypes o f CD4+ T cells, the former stimulating cell-mediated immunity and producing
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IFN-7 , IL-2 , and the latter stimulating humoral immunity and producing IL-4, IL-5 and
IL-10 (98). Productions o f Thl cytokines and Th2 cytokines often counteract each other
(98). There appears to be a shift in predominance o f helper T cell responses from type 1
to type 2 with advanced aging (81, 120, 121). Diversity in clonal expansion is a critical
feature o f T cell activation. However, restricted TCR repertoire has been found to be
associated with CD 8 + T cells (122-124). T cells can also be classified into naive versus
memory T cells. It is known the frequencies o f both CD4+ and CD 8 + naive T cells in
human peripheral blood decrease with age (125). Diminishing o f the naive cells is due to
thymic involution (125), which contribute to increased susceptibility to new pathogens in
older subjects. Accumulated memory T cells may impair the long term T cell activation
(79,126, 127). Naive/memory T cell ratio declines with age with CD 8 + more rapidly
than CD4+ T cells (128-130). Interestingly, the frequencies o f different subtypes o f T
cells do not change with age consistently at least for CD 8 + T cells. Gupta and Hong have
reported in human peripheral blood the frequencies o f naive (CD45RA+CCR7+) and/or
central memory T (TCM, CD45RO+CCR7+) CD 8 + cells are decreased with age,
whereas those o f effector memory cells (TEM, CD45RO+CCR7-) and effector (TEMRA,
CD45RA+CCR7-) CD 8 + T cells are increased with age (128, 131). Besides
conventional T cells, T regulatory (TREG) cells are also influenced by aging. TREGs
express Foxp3 transcriptional repressor and play an immuno-suppressive role in
maintaining immunological tolerance and homeostasis (132). It has been found TREG
number in human peripheral blood increases with age, which may lead to the imbalance
o f TREG homeostasis and predispose the aged individuals to higher risk o f autoimmune
diseases (133-135).

In humoral immune system, age-associated changes are indicated to be associated with B
cells in multiple aspects. With respect to proliferative responsiveness to signals, reduced
RNA synthesis and DNA replication upon stimulation with immunoglobulin (slg),
polyclonal activator staphylococcus aureus Cowan I (SAC), CD20 or CD40 have been
detected in aged human B cells (136). W ith respect to B cell genesis, studies have shown
increased longevity is associated with decreased number o f de novo B cells (137, 138)
but no change has been observed in the number o f peripheral blood B cells in mouse and
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human (120,139). Further more, Studies in human and mice also show aged mature B
cells exhibit altered B cell receptor (BCR) repertoire, particularly in V region (140).
Antibody production in majority o f B cells requires the assistance o f CD4+ T cells. T
cells interact with B cells and induce hypermutation in immunoglobulin genes in B cells.
The age-related dysfunction o f T cells in conjunction with the intrinsic impairment o f B
cells significantly affects the production o f antibodies in the elderly(141, 142). This is
reflected by more restricted antibody repertoire in the elderly than that in young people.
The malfunction o f humoral immune system results in the impaired primary and
secondary humoral responses to vaccination in older people (143, 144). For instance, the
peak titer o f antibody in older subjects tends to be lower and occurs later than in younger
subjects ( 1 2 0 ).
1.5 Overview o f Immune Responses to Influenza Virus
Influenza virus induces humoral as well as cell-mediated immune responses. Humoral
immunity plays a crucial role by providing protective antibodies to neutralize infectious
virion. Specific antibodies to HA, NA, NP, M l and M2 have been detected in human or
mouse in response to influenza infection but only HA and NA antibodies (IgM, IgG and
IgA) have been proven to possess primary protective function (1,145). Influenzainduced antibody can not provide life long protection against the disease. Possible
reasons include a diminution o f protective antibody with time and the rapid emergence o f
new viruses with unprecedented antigenic epitopes in HA (1, 146). CD4+ type 2 T (Th2)
cells mediate antibody production via physical contact with B cells and cytokine
secretion to stimulate B cell development and influence Ig subclass switching. IL-4, IL5, IL -6 and IL-10 are Th2 cytokines detected in response to influenza stimulation (147,
148). IL-4 has been found to stimulate the production o f IgG l and IgE in mice (149).

Cell mediated immune responses (CMI) to influenza virus involve cytotoxicity and Thl
cytokine production (150). Cytotoxicity is elicited by T cells and NK cells. MHC class
I-restricted CD 8 + cytotoxic T cells have been found to recognize influenza HA, M, NP
and PB2-derived antigens (151, 152). Recent data indicate that T cell cytotoxicity is not
restricted to CD 8 + T cells but extends to CD4+ T cells. MHC class Il-restricted porferin-
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mediated cytotoxicity by CD4+ T cells have been identified towards influenza vims and
other vimses (153, 154). NK cell-mediated cytotoxicity involves a variety o f NK cell
surface receptors and will be discussed in session 1.7. Type I T helper (T hl) cells play an
important role in mediating the responses to influenza infection and vaccination through
secreting cytokines such as IL-2 and IFN-y (7,150). In addition to T cells, NK cells
secrete large amount o f IFN-y in response to influenza stimulation (155, 156). T hl cell
and NK cell functions have been shown to be significantly modulated by antigen
presenting cells and/or their secreted cytokines (157-160), which will be addressed in
detail in session 1.6. Upstream to cytokine production, TLRs have been proven to
significantly contribute to immune activation in response to influenza vims. Toll-like
receptors (TLR) serve as the important sentinels for pathogen in the innate system and
largely mediate T hl immunity (161). Influenza vims contains a single stranded RNA
genome and produces dsRNA intermediate during its replication, thus is able to activate
TLR3, 7 and 8 constitutively expressed or induced in NK cells, pDC and/or monocytes
(162-164). Some activation may require an additional factor, such as IFN-y to facilitate
(165).

1.6 Significance o f Thl Immunity Induced by Influenza Stimulation in Aging

Influenza infection and vaccination induce humoral and cell-mediated immune responses
(CMI). CMI is believed to play an important role in conjunction with antibody response
for complete clearance o f influenza infection and largely determines the vaccine efficacy
(166). Age-associated impairment in CMI has been suggested to account for the
increased susceptibility to influenza in the elderly (150). Immune modulation via Thl
and pro-Thl cytokines is one important aspect o f influenza vims-induced CMI because
these cytokines function to stimulate T cell proliferation, display effector anti-viral
activity, modulate other cell function and influence antibody subclass profile (167). IL-2
and IFN-y are two well defined T hl cytokines. IL-2 is secreted by activated T cells and
has been shown to be indispensable in stimulating both Thl and cytotoxic T cell
proliferation, differentiation, and activating NK cells (168, 169). In addition, IL-2
enhances B-T cell interaction so as to contribute to antibody generation (170). IL-2
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production has been shown to be down-regulated or remain at a comparable level in older
subjects compared to young control in response to influenza infection and vaccination,
depending on specific experimental conditions, indicating influenza-related downregulation o f T hl immunity with aging is not solely attributed to the age-related changes
in IL-2 production (171-175). IFN-7 is a hallmark T hl cytokine and secreted by
activated T cells and NK cells upon influenza stimulation. Besides an effector cytokine
delivering direct anti-viral effect to viral infected cells, IFN-y is a critical immune
modulator and influences other immune cell function and antibody subclass profiling
(176). For instance, IFN-y has been known as the primary macrophage-activating factor
that up-regulates MHC class I and II molecules to stimulate antigen presentation and
influence expression o f other cytokines, chemokines to favor cellular antiviral
activities(176-178). In addition, it is able to up-regulate TLRs in macrophage and
epithelial cells (179). As a Thl cytokine, IFN-y stimulates Ig class switching in favor o f
IgG2a and IgG3 in mouse (180,181) and IgG l in human (182,183) in vitro and/or in
vivo (184). In human, systemic levels o f IgG l and IgG3 are important for complement
fixation and Ab-dependent cellular cytotoxicity (185). IgG is the dominant Ig subclass
stimulated by trivalent influenza vaccine and IgG l is the most prominent IgG isotype
(182, 186). IFN-y production has been shown to be down-regulated in older subjects in
response to influenza infection and vaccination (173, 187). Our recent data has indicated
that Thl response determined as the frequency o f IFN-y secreting CD4+ T h l and
cytotoxic influenza-specific memory T cells (ISMT) declines with age and correlates
with antibody response to influenza vaccination(174, 188). Consistent with our finding, a
new observation has indicated T hl but not antibody response correlated with the outcome
o f influenza vaccination (189). These evidences have suggested CMI, particularly Thl
immunity, contributes to reducing the morbidity and mortality o f influenza in the elderly
and capable o f influencing vaccine effectiveness.

The production o f IFN-y can he modulated by pro-Thl cytokines secreted by antigen
presenting cells. For instance, IFN-o/jS alone or synergistically with IL-18 is able to
induce type I T cell and N K cell activations (190). One prominent role o f IL-18 is to act
together with IFN-o//3, IL-12 and/or IL-23 to activate T hl and NK cells to induce IFN-y
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production and NK cytotoxicity (157,191-193). Although IL-12 and IL-23 are not
induced in human PBMC stimulated with influenza virus, IFN-O! /j3 is abundantly
produced by pDC and monocytes in response to influenza infection (48, 49, 194, 195). In
general, pDC is the predominant cell type in production o f type I IFNs responsive to viral
infection or CpG via TLR-7 or TLR9 pathway (196, 197). However, the accurate
comparison in the amount o f type IIF N production responsive to influenza infection
between pDC and monocytes has not been documented. In addition to direct antiviral
effect and induction o f IFN-y in T cells and NK cells, type I IFN and pDC has been
recently shown to mediate antibody production (198, 199). Although Type I IFNs and
pDC are demonstrated to play a significant role in antiviral immunity, how important
they are in influenza-induced immunity and how relevant they are to age-associated
decline in IFN-y production in response to influenza stimulation in human remains to be
investigated.

1.7 Significance o f NK Cell Activation Induced by Influenza Stimulation

As we described earlier in session 1.6, T hl immunity is important in response to influenza
stimulation and T hl response determined as the frequency o f IFN-y secreting CD4+ T
cells is declined in elderly subjects. NK cells secrete IFN-y in response to influenza
stimulation therefore participate in influenza-induced T hl immunity. However, how
IFN-y production in NK cells is maintained in older people in response to influenza
infection remains unknown. Our study will be focused on investigating the activation,
specifically the IFN-y production in human peripheral NK cells in response to influenza
virus and attempts to unravel the important regulatory factors that contribute to the ageassociated changes in NK cell activation in response to influenza virus.

•

Overview o f N K cells

NK cells are the major lymphocytes in the innate immune system. Capable o f eliciting
cytotoxicity to virus-infected or tumor cells via MHC class I molecule-dependent or
independent mechanisms, NK cells play a crucial role in controlling viral load at early
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stages o f infection and performing immune surveillance on tumorigenesis (82, 200). NK
cell function is mediated by a spectrum o f cell surface receptors (201, 202). NK surface
receptors can be classified into two categories, activating receptors and inhibitory
receptors. Activating receptors include natural cytotoxicity receptors (NCRs, NKp30,
NKp44 and NKp46), NKG2 family o f receptors (NKG2 A/B, C, D, E and F), CD 16,
CD244, CD161, and CD226 (DNAM-1) and CD96. NCRs recognize viral or tumor
molecules and trigger lysis in abnormal cells (200). NKG2 receptors form homodimers
or heterodimers with CD94 and generate either activating (NKG2C or D) or inhibitory
(NKG2A) effect through binding to MHC I chain-related proteins (203, 204). CD16
mediates direct and/or antibody-dependent cell-mediated cytotoxicity (ADCC) (205).
CD244 displays MHC class I-independent activating or inhibitory effects depending upon
stimuli (206). CD161 recognizes non-peptide antigens and is found to be co-expressed
with T cell receptors (TCR) on natural killer T (NKT) cells (207). CD226 and CD96
have been shown to recognize poliovirus receptor (PVR) and suggested to mediate
cytotoxicity and cell adhesion (208). NK cytotoxicity can be prevented by NK
inhibitory receptors Ly49, KIR and NKG2A/CD94 in a MHC-I-dependent manner (209,
210). NK cells express TLR 3 which enable them to recognize dsRNA and TLR7/8,
which enable them to recognize ssRNA (211,212). Activated NK cells produce IFN-y,
display cytotoxicity and mediate immune regulation. In addition to IFN-y, NK cells
secrete GM-CSF, which is known to be capable to induce monocyte differentiation into
mDC or macrophages in the presence or absence o f IL-4, respectively in vitro (213, 214).

•

N K cell activation in response to influenza virus

NK cell activation involves cytotoxicity, IFN-y production and cell proliferation and is
regulated by cell-cell contact factors and soluble cytokines, the latter through STATparticipated signal transduction pathways with ST ATI mediating cytotoxicity and
STAT4 inducing IFN-y production (215, 216).

NK receptors mediate cytotoxicity via MHC class I-dependent or independent
mechanism. In an MHC class I-independent manner, intact influenza viral protein HA
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cross-presented or attached to the surface o f infected cells, has been found to be
recognized by natural cytotoxicity receptors NKp44 and NKp46 via HA binding to the
sialic acid residue attached to galactose on the NCR receptors, supporting a significant
role of receptor-mediated cell-cell contact regulation in the NK cell activity specifically
in response to influenza stimulation (217-219).

NK cells comprise 2 major differentiation subsets differed by surface expressions o f
CD56 and CD16 (84). CD56dimCD16bnght NK cells preferentially execute cytotoxicity
and CD56dimCD16bnsht NK cells secrete IFN-y (84). In spite o f functional polarity
displayed by subsets o f NK cells, IFN-y production has been shown to correlate with the
lytic function in human peripheral NK cells (220), suggesting concordance in activity
between the two NK subsets. As we described earlier, NK cell IFN-y production can be
modulated by type I interferons via STAT4 signal transduction pathways (216). In fact,
NK cells not only produce IFN-y but are influenced by IFN-y for their activation. Human
peripheral NK cells exist in mature or immature status with mature cells being the
majority and able to produce IFN-y. IL13+ immature NK cells have been shown to be
able to differentiate into IL-13- cells in the presence o f IL-2 and further mature into IFNy producing cells by IFN-y (221). He and colleagues has postulated “T-cell dependent
production o f IFN-y by NK cells in response to influenza A virus” in a IL-2 dependent
manner, supporting the role o f IFN-y in NK cell differentiation and activation (222).
Thus, both type I interferons and IFN-y are playing a significant role in activating NK
cells in response to influenza infection. Unfortunately, the importance o f these soluble
factors in influenza-related immunity in an aging context remains unclear.

NK cell response to influenza stimulation is not restricted to infection but extends to
vaccination. Skoner and Mysliwska and colleagues have reported NK cytotoxicity can be
augmented during the acute phase and convalescent phase post vaccination with either
inactivated or live vaccine (155, 156). In addition, higher NK activity post vaccination
have been shown to correlate with higher HA antibody titer and better protection against
clinical infection (155, 156, 223). These evidences indicate NK cells may not only be
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important in defending against acute infection but also participate in preventing influenza
post vaccination.

NK cell frequency in peripheral blood increases with age but cytotoxic activity decreases
in the elderly in response to influenza infection and vaccination (87-90). IFN- y
production is one o f the most important activities o f NK cells. How aging influences NK
cell activation, particularly IFN-y production has far less been documented. In this study,
we have compared the frequency o f IFN-y producing NK cells in PBMC in response to
influenza infection between young and older subjects and investigated how aging
influences the regulatory components o f NK activation and consequently contribute to
the reduced IFN- y production in NK cells in response to influenza virus in the elderly.

1.8 Hypothesis and Specific Aims

As described earlier NK cell activation manifested by IFN-y production *n response to
influenza virus is regulated via soluble factors and cell-cell contact mechanism.
Specifically, pro-T hl/T hl cytokines IFN-O! and IFN- y along with NK cytotoxic receptors
(NCRs) and/or viral protein HA involved in cell-cell recognition between NK cells and
antigen presenting cells may play an important role in regulating NK cell activation.
How aging influences the regulatory factors for NK activity and leads to altered IFN-y
production in NK cells in the elderly in response to influenza virus have been the focus o f
this study. Components potentially contributing to NK cell IFN-y production in response
to influenza virus involved in current study are depicted in Figure 3.

•

Hypothesis

We hypothesize the impairment in soluble factors, such as the pro-T hl/T hl cytokines
secreted from pDC and T cells, and/or the defect in expression o f cell surface proteins
involved in cell-cell contact between NK cells and monocytes contributes to the downregulated NK cell activation in response to influenza virus in older subjects.
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Figure 3. NK cell IFN- 7 production and cytotoxicity in response to influenza virus is
regulated by proT hl/T hl cytokines as well as cell-cell contact
Influenza virus infects human PBMC and triggers IFN- a production in monocytes and
dendritic cells (pDC and mDC). IFN -a in conjunction with other cytokines, such as IL18, induces N K cell to generate IFN- 7 . At the same time, N K cytotoxicity and IFN - 7
production can be induced by physical contact o f NK cells with viral infected
monocytes via NK receptor-MHC I or viral HA protein recognition. Further more,
IFN - 7 secreted from T cells may activate monocytes and indirectly augment NK cell
activities. Grey circles represent IFN -a or IFN - 7 and white circles represent other
soluble factors.

•

Specific aims

To test this hypothesis, the following two specific aims have been addressed:

1. To examine to what extent the impairment in soluble factors, particularly the pro-Thl
cytokines secreted by pDC and T cells play a role in the reduced IFN - 7 production in NK
cells in response to influenza virus in older subjects.
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2. To examine to what extent the reduced IFN-y secretion by NK cells in older subjects is
due to changes in the expression o f cell surface receptors/proteins involved in cell-cell
contact regulation in NK cell activation in response to influenza virus.
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II. MATERIALS AND METHODS

II. 1 Experimental Design

The following schematic graph (Figure 4) describes the experimental design o f this study.
The study was focused on investigating the factors regulating and contributing to the
down-regulation o f NK cell activation, specifically IFN - 7 production in NK cells in older
subjects compared to young subjects in response to influenza virus. To achieve Specific
A im l, we propose to confirm the roles o f IFN -a and IFN-y in regulating NK cell
activation in response to influenza virus followed by investigating how aging influences
cytokine-producing cells pDC and T cells and consequently influences NK cell IFN-g
production. To achieve Specific Aim 2, we propose to confirm the roles o f cell-cell
contact between NK cells and antigen presenting cells in regulating NK cell activation in
response to influenza virus followed by examining how aging influences components
involved in the cell-cell contact regulation.

II.2 Human Subjects and Cells

•

Human subjects and peripheral blood mononuclear cells (PBMC)

Healthy young (21-45 years old) and healthy older (60 years and older) volunteers were
recruited to this study upon proper consenting. All documents related to recruiting
human subjects for this study were approved by Institutional Board Review (IRB) at
Eastern Virginia Medical School. PBMC were processed at room temperature (RT) from
heparinized whole blood. Briefly, the whole blood was centrifuged at 320 g for 10 min.
Buffy coat (PBMC) were aspirated and laid onto a Ficoll reagent, histopaque 1077
(Sigma-Aldrich, St. Louis, MO) followed by centrifugation at 650 g for 30 min. After
Ficolling, PBMC were washed twice with RPMI media (Invitrogen, Carlsbad. CA) by
centrifugation at 500 g and 320 g sequentially for 10 min each time, counted by
automatic counter machine (Coulter Ac • T, Beckman Coulter, Miami, FL) and re
suspended in CTL media (RPMI1640 media containing 10% FBS, 2 mM o f L-Glutamine,
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100 U o f penicillin, 100 /tg/ml o f streptomycin and 55 nM o f 2-mercaptoethanol) at a
concentration o f 1 million PBMC per ml for downstream experiments.

OBSERVATION:
One aspect of NK cell activation (IFN-g secretion) in response to influenza virus is down-regulated in
older subjects.
HYPOTHESIS:
Defects in soluble factors and/or cell-cell contact regulation contribute to NK cell activation downregulation in response to influenza viurs in older people

SPECIFIC AIM 1:

SPECIFIC A IM 2:

Role of soluble factors, particularly proT hl/T hl cytokines IFN-a and IFN-g

Role of molecules involved in cell-cell contact regulation,
particularly NKp44, NKp46 and influenza HA

EXPERIMENTS:

EXPERIMENTS:

1) Examine the correlations between NK cell
activation, amount of IFN-a in PBMC and T cell
activation in response to influenza virus.

1) Examine to how NK cell activation in response to
influenza vims relies on soluble factors versus cell-cell
contact regulation.

2) Examine the effects o f IFN-a and IFN-g on
NK cell activation in response to influenza virus.

2) Compare the expression of NK cell receptors
NKp44 and NKp46 between young and older subjects.

3) Examine the effects o f pDC and T cells on
NK cell activation in response to influenza virus.

3) Compare the expression of influenza HA on
influenza-stimulated monocytes between young and
older subjects.

4) Examine the frequency of and functional
changes inpD C and/or T cells andpDCmediated NK cell activation in response to
influenza vims in older people as compared to
young adults.

4) Examine the frequency of monocytes in PBMC and
monocyte-mediated NK cell activation in response to
in flu en za v im s in older people as compared to young
adults.

Figure 4. Experimental design o f the current study

II. 3 Influenza Virus

•

Propagation o f influenza virus

The influenza virus used in this study was A/Sydney/05/97 (H3N2, Bio-safety level II,
seed virus from Center for Disease Control, Atlanta, GA). The A(H3N2) subtype
emerged in 1968 and is present in influenza trivalent vaccine (TIV) (16, 224). The virus
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was propagated in embryonic chicken eggs by our lab staff. Briefly, fertilized chicken
eggs (CBT Farms, Chester Town, MA) were incubated at 37°C for 10 days. The viability
o f the embryos was checked with candle in dark. At room temperature, 0.1 ml o f 1:1000diluted seed virus in diluent buffer (lx PBS, pH 7.2 containing lOOU/ml penicillin,
1 0 0 jag/ml

streptomysin and 50/xg/ml gentamycin) was injected to the egg from ethanol

(70%)-sprayed top o f the egg with 1 -ml tuberculin syringe attached to a 2 2 gauge-oneinch needle under sterile conditions. Injection site was sealed with glue and the eggs
were incubated at 37°C for 48 more hours before being harvested. For harvesting
allantoid fluid, ethanol-sprayed top o f eggs was broken and allantoid fluid was collected
with a sterile pipette. Allantoic fluid containing A/Sydney virus was filtered via 0.4 umpore size nitrocellulose membrane and was aliquoted into working size and stored at the 80°C until use. The aliquots were used only once to minimize freeze-thaw cycle. All
procedures were conducted under the Guidelines for Bio-safety as detailed in the
Biosafety in Microbiological and Biomedical Laboratories (BMBL) published by the
CDC and by the Office o f Safety at the Eastern Virginia Medical School.

•

Titration o f influenza virus

The viral stock contained 107 tissue culture infectious dose 50 (TCID50)/ml o f live viruses
as tested in Madin-Darby canine kidney (MDCK) cells and 1024 hemagglutinin unit
(HAU)/50ul as tested with chicken red blood cells. For procedures to determine TCID 50,
please refer to Karber’s method described in the reference(225). To determine HAU,
fifty microliter o f 1:20 diluted viral stock in PBS (pH 7.4, GIBCO/Invitrogen, Carlsbad,
CA) was placed in the first column o f V-bottom 96-well plate (in duplicates and serially
diluted at 1 :2 ratio for the remaining columns with each well in the columns containing
50 /xl o f the diluted virus. Fifty microliter o f 0.5% chicken red blood cells (CRBCs) was
added to each well and the plate was incubated at room temperature for 45 min.
Agglutination was evaluated and using the criteria described earlier(l 1). HAU was
calculated according to the formula HAU/50 jil =10x2", where n is the highest column
number in the plate where agglutination occurs.
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II.4 Assays and Specific Methods

•

Live cell staining, intracellular cytokine staining and flo w cytometry

For cell surface antigen only staining, 1 million or less live cells were co-stained with
fluorescent-conjugated antibodies against cell surface antigens in 1 % BSA-PBS at a
volume o f 26 fil per well in 96-well U-bottom tissue culture (TC) plate at RT for 20 min
followed by 2 times o f washing with 1%BSA-PBS. The cells were then re-suspended in
200 pd o f 1%BSA-PBS, placed on ice and ready for flow cytometry analysis
(FACSCalibur, BD Biosciences, San Diego, CA). For analysis, forward scanner (FSC)
and side scanner (SSC) were used to gate PBMC or specific cell types together with
specific antigens. A total 20,000 to 200,000 events per sample, depending on the relative
proportion o f cells o f interest were saved for analysis (CellQuest 3.3 software, BD
Biosciences, San Diego, CA). For intracellular cytokine staining, cells were fixed with
1% paraformaldehyde-PBS, permeablized with permeablization buffer (Becton
Dickinson, San Diego, CA) followed by one time washing with 150 ju.1 o f 1%BSA-PBS.
Then the cells were treated the same way as for live cell staining.

•

Detection o f cell activation by Fastlmmune (FI) assay

Fasthnmune assay consists o f 2 consecutive procedures, culture set-up followed by
intracellular cytokine staining and flow cytometry. To set up cultures, one million
PBMC, pDC-, T cell- or NK cell-deducted PBMC, or different amount (see
corresponding figure description in result session) o f selectively isolated cells were
stimulated with or without 1 pd (104 TCID 50) o f influenza virus A/Sydney in 150 pd o f
cytotoxic T lymphocytes (CTL) media in 96-well U-bottom TC plate at 37°C overnight.
Brefeldin A, a reagent that interferes with protein trafficking so that newly generated
cytokines can be trapped inside the cell for intracellular cytokine staining (BFA, SigmaAldrich, St. Louis, MO) was added to each well at 5pig/ml with total culturing volume
brought up to 180 ul (226, 227). The culture was incubated at 37°C for 3 more hours
after addition o f BFA and supernatants were removed from the cells or saved when
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needed, before the cells were fixed and analyzed by intracellular cytokine staining and
flow cytometry. The total culture incubation time was 20-24 hours in this assay. To
detect NK and T cell activation, anti-CD3 (FITC), CD56/16 (PE), CD69 (PerCP), and
IFN-y (APC) antibodies were used in intracellular cytokine staining. To detect pDC
activation, anti-IFN-o2 (PE, Chromaprobe, Maryland Heights, MO), CD69 (PerCP) and
CD 123 (APC) antibodies (BD Biosciences, San Diego, CA) were used in the staining.
Flow cytometry was used to determine the frequency o f cytokine secreting cells as well
as the per-cell-based geometric mean intensity o f fluorescent. In some experiments to
detect early production o f cytokines, BFA was added 4 hours posterior to stimulation o f
cells with A/Sydney and the culture was continued at 37°C overnight followed by
intracellular cytokine staining and flow cytometry analysis. W hen needed, IFN -a
neutralizing antibody (polyclonal, Biosource, Miami, FL), IFN-a//3 receptor neutralizing
antibody (monoclonal, Cellsciences, Inc, Vanton, MA), IFN-y neutralizing antibody
(monoclonal, R&D Systems, Minneapolis, MN), rIFN-02 (PBL Biomedical Laboratories,
Piscatawaym NJ), rIFN-y (Invitrogen, Carlsbad, CA) or CpG (ODN2216 at a final
concentration o f 6 pig/ml, MWG-Biotech, high Point, NC), rIL-12 (p70, PharMingen, San
Diego, CA) was added to the culture to examine their effects on A/Sydney-induced NK
or T cell activation.

•

Measurement ofpD C, monocyte, and T cell frequencies in PBMC

Live cell staining and flow cytometry were used to examine frequencies o f various cell
types in PBMC. For measuring pDC frequency, 1 million PBMC were co-stained with
human lineage markers (including anti-CD3, CD14, CD16, CD19, CD 20 and CD56,
fluorescein isothocyanate, or FITC-labeled antibodies), CD123 (phycoerythrin, or PElabeled), HLA-DR (peridinin chlorophyll protein, or PerCP-labeled) and CD1 lc
(allophycocyanin, or APC-labeled) antibodies (BD Biosciences, San Diego, CA)
followed by 2 washes. For measuring monocyte and T cell frequencies, 1 million PBMC
were co-stained with anti-human CD14 (FITC), CD3 (PE), CD 8 (PerCP), and CD4 (APC)
followed by 2 washes. Following staining, flow cytometry was used to determine the
frequency o f each cell type.
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•

Isolation o f pD C

Plasmacytoid DC were isolated by using BDCA4 cell isolation kit (Miltenyi Biotec,
Auburn, CA). Briefly, every up to 108 PBMC were incubated with 300 ji\ o f MACS
buffer (0.5%BSA and 2mM EDTA in PBS, pH7.2), 100 /d o f FcR blocking reagent and
100 /d o f anti-BDCA4 magnetic micro-beads at 4°C for 15min followed by one time
wash with 7.5 ml o f MACS buffer. The cells were then separated by running through MS
column placed in a magnetic field. BDCA4+ cells (pDC) retained in the column were
eluted after magnetic field was removed. Isolated pDC and pDC(-) PBMC were re
suspended in CTL media and counted by automatic counter machine (Coulter Ac *T,
Beckman Coulter, Miami, FL). A portion o f isolated cells were stained with anti-lineage
marker (FITC), CD123 (PE), HLA-DR (PerCP) and CD1 lc (APC) antibodies (BD
Biosciences, San Diego, CA) followed by flow cytometry to examine the purity. The
purity ranged from 70% to over 95% depending on the amount o f starting PBMC and
donor. More PBMC was associated with higher purity. Because pDC exist in PBMC at a
low frequency (0.1-0.5%) and the amount o f PBMC obtained from each individual was
limited, in some experiments when relatively larger amount o f pDC was needed, PBMC
from 2 to 8 subjects, depending on the availability o f subjects, in young or old group
were pooled for pDC isolation. The pooled PBMC comprises equivalent amount o f
PBMC from each subject o f the same age group.

•

Isolation o f monocytes

Monocytes were isolated by using anti-CD 14 micro-beads (Miltenyi Biotec, Auburn, CA).
Briefly, up to 107 PBMC were incubated with 80 /xl o f MACS buffer and 20 /d o f antiCD14 micro-beads at 4°C for 15min followed by one time wash with 1.5 ml o f MACS
buffer. The cells were then separated by running through MS column (Miltenyi Biotec,
Auburn, CA) placed in magnetic field. CD 14+ cells (monocytes) retained in the column
were eluted after magnetic field was removed. Isolated cells were re-suspended in CTL
media and counted by automatic counter machine (Coulter Ac *T, Beckman Coulter,
Miami, FL). A portion o f cells were stained with anti-CD14 (FITC, BD Biosciences, San
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Diego, CA) and CD56 (APC, Miltenyi Biotec, Auburn, CA) antibodies followed by flow
cytometry to examine the purity

•

Isolation N K cells and T cells

NK cells were isolated by using anti-CD56 magnetic micro-beads or NK cell isolation kit
II (Miltenyi Biotec, Auburn, CA). By using anti-CD56 micro-beads, up to 107 PBMC
were incubated with 20 pd o f anti-CD56 micro-beads and 80 pd o f MACS buffer at 4°C
for 15min followed by one time o f wash with 1.5 ml o f MACS. The cells were then
separated by running through MS column placed in magnetic field. CD56+ cells (NK)
retained in the column were eluted after magnetic field was removed. CD56+ NK cells
and CD56(-) PBMC were re-suspended in CTL media and counted by automatic counter
machine (Coulter Ac *T, Beckman Coulter, Miami, FL). A portion o f isolated cells were
stained with anti-CD 14 (FITC, BD Biosciences, San Diego, CA) and CD56 (APC,
Miltenyi Biotec, Auburn, CA) antibodies followed by flow cytometry to examine the
purity. By using NK cell isolation kit, up to 107 PBMC were incubated with 10 pd o f
biotin-conjpigated antibodies against CD3, CD4, CD 14, CD 15, CD 19, CD 123 and
glycophorin and 40 pd o f MACS buffer (0.5%BSA and 2mM EDTA in PBS, pH7.2) at
4°C for 10 min followed by incubation with 20 pd o f anti-biotin micro-beads and 30 pd o f
MACS buffer at 4°C for 15min. The cells were then washed once with 7.5 ml o f MACS
buffer and applied to LS column for separation. Positively labeled un-related cells were
retained in the column and untouched NK cells were enriched in the eluted buffer.
Isolated cells were re-suspended in CTL media and counted by automatic counter
machine. A portion o f isolated cells were stained with anti-CD3 (FITC), CD56/16 (PE),
and CD 14 (APC) antibodies (BD Biosciences, San Diego, CA) followed by flow
cytometry to examine the purity. T cell isolation procedure was similar to that o f NK
isolation by using anti-CD56 micro-beads except that anti-CD3 instead o f CD56 micro
beads was used. Anti-CD3 (FITC), CD56/16 (PE), and CD14 (APC) antibodies were
used for staining to examine the purity.
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Quantification o f IFN-a by ELISA

•

Supernatant from Fastlmmune PBMC or influenza virus-stimulated pDC were examined
for IFN-a levels using human IFN -a ELISA kit (Biosource, Camarillo, CA). Briefly,
supernatant at 1:25 dilution and standards were incubated in 96-well plate wells coated
with capturing antibodies recognizing multi-subspecies o f IFN-a including subtypes A, D,
K, G, C, J but not B2, F and H. Then detecting antibody (secondary antibody), anti
secondary antibody conjugated to horseradish peroxidase (HRP) and substrate
tetramethyl-benzidine (TMB) were used sequentially for the rest o f the assay following
manufacturer’s instruction. The plates were read at 450 nm by PowerReportsx ELISA
reader and analyzed with KC4 (version 3.0) software (Bio-Tek Instruments, Inc.,
Winooski, VT).

•

Stimulation o fp D C o f young and older subjects

To compare IFN -a level secreted by pDC between young and older people, 0.05 m illion
pDC isolated from pooled PBMC from 2-6 young subjects or 4-8 older subjects were
stimulated with 1 /d o f influenza virus in 96-well U-bottom plate at 37°C in the absence
o f BFA. Supernatants were collected the next day and examined for IFN -a level by
ELISA.

•

Examination o f effect o f supernatant on N K cells

One million PBMC were stimulated with or without 1 /d o f influenza virus under regular
Fastlmmune (FI) assay culture set-up conditions except for in the absence o f BFA.
Supernatants from cultured wells were collected the next day and utilized to stimulate
autologous NK cells isolated from PBMC. Each well containing 0.2 million isolated NK
cells in 20 /d o f CTL media in conjunction with 130 /d o f cultured supernatant was
incubated at 37°C overnight before BFA was added to the culture. All other conditions
were same as in regular FI assay.
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•

Transwell experiment

Three million CD56 (-) PBMC were placed in regular 24-well plate and stimulated with
or without 20 pi o f influenza virus in 700 /d o f CTL media. CD56+ NK cells were
placed in transwell (Fisher Scientific, Pittsburgh, PA) at 0.2 million per well in 50 pi o f
CTL media. As a control, equal amount o f NK cells were mixed with CD56 (-) PBMC in
a regular well. The plate was incubated at 37°C overnight followed by regular FI
procedures for intracellular cytokine staining and flow cytometry to detect IFN-y
secretion by CD56+ N K cells. Anti-IFN-y (FITC, BD Biosciences, San Diego, CA),
CD69 (PE, BD Biosciences, San Diego, CA) and CD56 (APC, Miltenyi Biotec, Auburn,
CA) antibodies were used in the staining.

•

Examination o f NKp44 and NKp46 expressions on N K cells in PBMC

One million resting PBMC or PBMC stimulated with or without 2 pi o f influenza virus in
regular FI procedure but in the absence o f BFA were examined for NKp44 and NKp46
expressions by live cell, indirect staining. Briefly, PBMC were stained with mouse-antihuman NKp44 antibody (R&D Systems, Minneapolis, MN) followed by secondary
antibody, goat-anti-mouse IgG (FITC, Jackson Immuno Research, West Grove, PA),
staining. After blocking with normal mouse serum, the cells were co-stained with anti
human NKp46 (PE, R&D Systems, Minneapolis, MN), CD3 (PerCP) and CD 19 (APC)
antibodies (BD Biosciences, San Diego, CA) followed by two washes. Flow cytometry
was used to determine the intensity o f fluorescent level o f NKp44 and NKp46 on NK
cells identified by excluding CD3+, CD 19+ lymphocytes and morphologically different
monocytes from PBMC.

•

Examination o f influenza HA expression on monocytes in PBMC

One million resting PBMC or PBMC stimulated with or without 1 pi o f influenza virus as
in regular FI procedure but in the absence o f BFA were examined for HA expression on
monocytes by live cell, indirect staining. Briefly, PBMC were stained with mouse anti-
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HA (for H3 subtype o f influenza A virus only, Chemicon International, Inc, Temecula,
CA) followed by secondary antibody staining with goat-anti-mouse IgG (FITC, Jackson
Immuno Research, West Grove, PA). After blocking with normal mouse serum, the cells
were co-stained with anti- CD69 (PerCP) and CD 14 (APC) antibodies (BD Biosciences,
San Diego, CA) followed by two times o f wash. Flowcyotmetry was used to determine
the intensity o f fluorescent level o f HA and CD69 on CD 14+ monocytes.

•

Experiment o f differential effect ofyoung or aged pD C on N K cell activation

Plasmacytoid DC o f young and older subjects, namely pDC(Y) and pDC(O) respectively,
were isolated from pooled PBMC from 2-3 donors. One million PBMC o f each young or
older subject or 1 million pDC(-) pooled PBMC were stimulated with 1 pi o f influenza
virus with or without addition o f 0.01 million pDC(Y) or pDC(O). That equal amount o f
pDC(Y) and pDC(O) was added to the culture was verified by measuring the frequency
o f pDC by live cell staining and flow cytometry with pDC identification antibodies
described earlier. Other conditions for culture set-up and detection o f NK cell activation
were same with those in regular FI procedures. Three independent experiments involving
a total o f 8 young and 8 older subjects were performed.

•

Crossover experiment o f monocytes between young and older subjects

CD 14+ monocytes o f young and older subjects, namely Mono(Y) and Mono(O),
respectively, were generated by pooling equal amount o f PBMC from 2-3 individual.
One million CD14(-) PBMC o f each young or older subject were stimulated with 1 pi o f
influenza virus with or without addition o f 0.1 million CD14+ Mono(Y) or pDC(O).
Equal amount o f Mono(Y) and Mono(O) added to the culture was verified by measuring
the frequency o f added CD 14+ monocytes using live cell staining and flow cytometry
with anti-CD 14 antibody. Other conditions for culture set-up and detection o f NK cell
IFN-y production were as same as in regular FI procedures. Four independent
experiments involving a total o f 10 young and 10 older subjects were performed.
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II. 5 Statistical Analysis

All statistical analysis was done by using SPSS software. Two-tailed non-parametric
Mann-Whitney test or Sign test was used to compare differences between groups when
variables were not suggested to follow normal distribution by normality test or sample
size was relatively small. Two-tailed t test or ANOVA was used when sample size was
relatively big and normality test suggested normal distribution.
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III. RESULTS
III. 1 Down-regulation o f NK Cell Activation in PBMC in Response to Influenza Vims in
Older People

•

N K cell activation determined as IFN-y production in response to influenza virus
was down-regulated in older subjects

Knowing NK cells secrete a significant amount o f IFN-y in response to influenza vims,
we first wanted to know whether there was a difference in IFN - 7 production NK cells in
influenza vims-stimulated PBMC between young and older people. We used an
activation priming marker CD69 in conjunction with IFN-y to monitor NK cell activation.
By comparing IFN-y secretion between 18 healthy young and 25 healthy older subjects
by Fastlmmune (FI) assay, we found upon influenza viral stimulation o f PBMC, both the
frequency o f CD69+IFN-Yt‘ NK cells and the per-cell-based intensity o f IFN-y were
significantly less in older subjects than those in the young subjects (p<0.001, Figure 5A,
B and C). The frequency o f CD69+IFN-Y+ NK cells and per cell-based IFN-y intensity
among total NK cells was 14.9+2.2% (mean+s.e.m.) and 320+156 (mean+s.d.),
respectively in the young subjects and 2.8+1.8 % (mean+s.e.m.) 232+101 (mean+s.d.),
respectively in the older subjects (Figure 5B left). Significant lower frequency o f
activated NK cells was also found in older subjects when total lymphocytes instead o f
N K cells were used as the denominator (0.85+0.17% in the young and 0.24+0.13% in the
old, mean+s.e.m., p=0.002, Figure 5B right), indicating the aging-related up-regulation o f
overall NK cell frequency in lymphocytes (6.4+3.2% in the young and 12.0+3.2% in the
old, mean+s.d., p=0.001) was not adequate to compensate the reduction in number o f NK
cells secreting IFN-y m response to influenza vims in older people (S. Figure 1).

We

could not find significant difference in CD69 intensity in either CD69+IFN-7+ or
CD69+EFN-Y- NK cells (S. Figure 2A) or in CD69+IFN-Y- NK cell frequency (S. Figure
2A) in total NK cells between young and older subjects, indicating early signal
transduction event in NK cell activation in influenza-vims stimulated PBMC is relatively
well preserved with aging.
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Figure 5. Down-regulation of IFN - 7 production in NK cells in PBMC in response to
influenza virus in older subjects
One million PBMC from each of 15 healthy young and 25 healthy older subjects were
stimulated with 1 /il of influenza virus in 96-well plate overnight. Fastlmmune assay and flow
cytometry was used to determine the frequency of CD69+IFN-/y+ NK cells. A, CD56+orl6+
NK cells were gated out of lymphocytes and analyzed for CD69 and IFN-y expression by flow
cytometry. An example of expression of CD69 and IFN-y in NK cells in a young and an older
subject was presented. B, comparison of CD69+IFN-y+ NK cell frequency in total NK cells
(left graph in panel B) and lymphocytes (right graph in panel B) between young and older
subjects. Horizontal bars represent the mean. C, Average intensity of IFN-y in CD69+IFN-y+
NK cells in young and older subjects. Error bars represent standard deviation.
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•

Down-regulated N K cell IFN-y production in response to influenza virus in older
subjects was associated with reduced T cell activation and IF N -a secretion in
PBMC

We next wanted to examine whether down-regulated NK cell activation in older subjects
in response to influenza stimulation was associated with changes in other factors in
PBMC. We examined a subset o f the same samples studied in Figure 4 for supernatant
level o f IFN-O! by ELISA and T cell (CD3+) activation by flow cytometry and found both
IFN-a levels in supernatant and the frequency o f CD69+IFN-yf T cells were significantly
reduced in older subjects compared to the young subjects (Figure 6 , p=0.002 and p<0.001 for
IFN-a level and activated T cell frequency, respectively). The supernatant IFN -a levels
and the frequency of CD69+IFN-yf T cells among total T cells were 12.3+4.8 ng/ml
(mean+s.d.) and 1.42+0.36% (mean+s.e.m.), respectively, in the young subjects,
compared to 7.5+4.5 ng/ml (mean+s.d.) and 0.30+0.26% (mean+s.e.m.), respectively, in
the older people. Then we calculated the correlation coefficients, which measure the
linear relationship between frequency o f activated NK cells, supernatant IFN -a level and
frequency o f activated T cells. We found the frequency o f CD69+IFN-'y+ NK cells in total
NK cells moderately correlated with IFN-a level in supernatant (r=0.56) and highly correlated
with the frequency o f CD69+IFN-y+- T cells in total T cells (r=0.86) (Table II), indicating
down-regulated NK cell IFN-y production in response to influenza virus in older subjects
was associated, though not necessarily in a causal/effect relationship, with reduced T cell
activation and IFN -a secretion in PBMC. The fact that poor correlation between
supernatant IFN -a level and frequency o f IFN-Y+ T cells (rO .35) indicates the
relationship between these two variables is at least not linear in our experimental system
(Table II).
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Figure 6 . Reduced level of IFN-a and lower frequency of IFN-7 -producing T cells in
PBMC in response to influenza virus in older subjects
A subset of the same samples studied in Figure 4 (One million PBMC from 12 healthy
young and 18 healthy older subjects stimulated with 1 /xl of influenza virus) was analyzed
for T cell IFN-y production and IFN-a secretion. Supernatants saved from the same wells
that were examined for NK and T cell activation were analyzed for IFN-a by ELISA. A,
supernatant IFN-a level in young and older subjects. B, frequency of CD69+IFN-y+ T
cells in total T cells in young and older subjects. T cells were identified by CD3+
antibody. Horizontal bars represent the mean.
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Table II. Correlation between frequency o f activated NK cells*, supernatant IFN -a level,
and frequency o f activated T cells* in young and older subjects

Age groups

Young and old

Young only

Old only

and variables

IFN -a

Frequency o f

IF N -a

Frequency o f

IFN -a

Frequency o f

to analyze

level

activated T cells

level

activated T cells

level

activated T cells

0.56

0.86

0.49

0.77

0.32

0.95

Frequency o f
activated NK
cells

IFN -a level

0.35

0.09

0.27

* Frequencies o f activated NK cells or T cells are expressed as the percent o f total NK or
T cells that are CD69+IFN-yF.

III.2 IFN -a and IFN - 7 Regulated NK Cell IFN-y Production in Response to Influenza
Virus

•

Neutralizing antibodies against IFN-a or IFN-a receptor down-regulated N K cell
activation in response to influenza virus

To find whether down-regulation o f IFN - 7 production in NK cells was a potential
outcome o f down-regulation o f IFN -a secretion in PBMC upon influenza viral
stimulation, we first asked how important IFN -a was in regulating NK cell IFN -7
production in response to influenza virus. By performing FI assay with adding anti-IFNa or anti-IFN-ojS receptor neutralizing antibodies to PBMC from healthy young subjects,
we observed NK cell activation determined as the frequency o f CD69+IFN-y+- NK cells
in total NK cells were down-regulated in a dose-dependent manner with the increased
dose o f either antibody (Figure 7). There was no significant difference in NK cell
activation between the treatments without antibody and with the control antibody
containing equivalent amount o f IgG to that in the well bearing highest neutralizing unit
o f antibody. Our data clearly indicates the importance o f IFN -a in mediating NK cell
IFN - 7 production specifically in response to influenza virus, supporting that age-related
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changes in IFN -a production, if any, bears the potential to contribute to the age-related
impairment in NK cell IFN-y production in response to influenza virus.
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Figure 7. Neutralizing antibodies against IFN-o: or IFN-cF/3 receptor down-regulated NK
cell activation in response to influenza virus in PBMC
One million PBMC from 9 healthy young subjects were stimulated with 1 /zl o f influenza
virus in the presence of different doses of IFN-o: or IFN-o: receptor netralizing antibodies.
Fastlmmune assay and flow cytometry was used to determine the frequency of
CD69+IFN-'y+ NK cells. A, with anti-IFN-G! antibody. B, with anti-rFN-o: receptor
antibodv. Horizontal bars represent the median.
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•

CpG up-regulated N K cell activation in response to influenza virus

To further confirm the role o f IFN -a in up-regulating NK cell IFN-Yprodution in
response to influenza virus, we used CpG ODN2216, a TLR-9 agonist that induces IFN -a
production in pDC to examine whether up-regulation o f IFN-a would enable NK cells in
PBMC to produce more IFN-y in response to influenza virus. By performing regular FI
assay with or without addition o f CpG to influenza viral stimulated PBMC from healthy
young subjects, we found in the presence o f CpG both the frequency o f IFN-a+ cells and
per-cell-based IFN -a intensity in CD123hi (a manifest o f pDC) but not CD1231ow
(related to monocytes and mDC) cells were significantly increased (p<0.05, Figure 8 A).
At the same time the frequency o f activated NK cells was up-regulated (p<0.05, Figure
8 B).

This result, consistent with that in Figure 7, confirms the significant role o f IFN-a

in mediating NK cell IFN-y production in PBMC in response to influenza virus.

•

Effects o f anti-IFN-y neutralizing antibody on N K cell IF N -y production in PBMC
in response to influenza virus

In addition to IFN-a, we also wanted to examine the role o f IFN-y in NK cell activation
to influenza stimulation. Similarly, we performed regular FI assay, in which different
doses o f anti-IFN-Y neutralizing antibody were added to influenza viral stimulated PBMC
from healthy young subjects, and monitored frequency o f IFN-y producing NK cells. At
concentrations o f 0, 0.25, and 0.5 pg o f antibody per 150 p\ o f reaction volume, there was
a trend o f the dose-dependent reduction in the frequency o f activated NK cells, but it
didn’t reach the significant level o f o=0.05 (Figure 9). It should be noted that an
antibody dose-dependent down-regulation o f NK cell activation occurred in all three
subjects with higher (3.3-7.1%) baseline (in the absence o f antibody) levels but not in
subjects with relatively low (0.1 -0.7%) baseline levels o f NK cell activation. This
seemed to suggest that baseline level o f IFN-y lower than certain limit may not respond
effectively to the neutralizing antibody. Increasing sample size and dividing subjects
based on their baseline responsive level to influenza virus may help clarify the results. In
conclusion, the importance o f the role o f IFN-y in regulating N K cell IFN-y production
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Figure 8. Effects of CpG on production of IFN-a and NK IFN-y in PBMC
One million PBMC from 6 (A) or 3 (B, the 3 subjects in B were also participating in A) healthy
young subjects were stimulated with 1 /xl of influenza virus in the presence of 6 ng/ml of CpG
ODN2216. CpG was added 4 hours after initiation of influenza infection. Fastlmmune assay and
flow cytometry was used to determine the intensity of IFN-a, frequency o f IFN-ofrCD123hi or
low cells and CD69+IFN-y+ NK cells. A, IFN-a+ cell frequency and IFN-a intensity in CD123hi
or low cells in the presence or absence of CpG. B, activated NK cell frequency in the presence or
absence of CpG. Horizontal bars represent the median.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

42

a?
CO

8

n

X

^ u.4 2 +

A

O

X

♦

A

$

*
W 0
Q.

0

0.25

0.5

1

2

ug of anti-IFN-g per 150 ul of reaction volume

Figure 9. Effects of neutralizing antibody against IFN-y on NK cell IFN-y production in
response to influenza virus in PBMC
One million PBMC from 6 healthy young subjects were stimulated with 1 /d of influenza virus
in the presence of different doses o f IFN-y neutralizing antibody. Fastlmmune assay and flow
cytometry was used to determine the frequency of CD69+IFN-y+ NK cells. Horizontal bars
represent the median.

could not be verified by the usage o f anti-IFN-y neutralizing antibody.

•

IFN-y facilitated monocytes to activate N K cells in response to influenza virus

To clarify the role o f IFN-y in NK cell activation regulation, we decided to use isolated
cells to avoid actions taken at one time by too many regulatory factors in PBMC in
response to influenza stimulation. Because rIFN-y alone or in conjunction with influenza
virus could not activate NK cells to produce IFN-y while monocytes are able to be
activated by IFN-y and capable to produce NK-activating cytokines, such as IFN-a, IL-18,
and IL-15, a cytokine that shares similarity with IL-2 in stimulating NK activation, we
isolated monocytes and NK cells from resting PBMC from healthy young subjects by
using CD14+ micro-beads and untouched CD56/16 NK cell isolation kit, respectively
and examined the effect o f rIFN-y on NK cell activation to influenza viral stimulation in
the presence or absence o f monocytes. In the presence o f monocytes, influenza virus in
conjunction with rIFN-y effectively activated NK cells and induced NK cell IFN-y
production in a rIFN-y dose-dependent manner (Figure 10A and B). These results
confirmed the important role o f IFN-y in regulating NK cell IFN-y production in response
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to influenza virus and provided the possibility that the age-related down-regulation in NK
IFN-y production might be due to age-related reduction, if any, in IFN- y production prior
to activation o f NK cells in PBMC.
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Figure 10. Recombinant IFN-y positively regulated NK cell activation in the presence of
monocytes in response to influenza virus
One fifth million isolated monocytes ( by CD 14 beads) and 0.2 million autologous NK cells
(including both CD56+ or CD 16+ NK but untouched) from 2 or 3 healthy young subjects
were stimulated with 1 gl of influenza virus in the presence or absence of different doses of
rlFN-Y- FI assay and flow cytometry was used to determine the frequency o f CD69+IFN-yr
NK cells. A. NK cell activation in the presence or absence of influenza virus or 100 ng/ml
of rlFN-Y B, NK cell activation to influenza virus in the presence of different doses of
rlFN-Y

III. 3 Plasmacytoid DC and T cell Regulated NK Cell Activation in Response to
Influenza Virus

We have shown previously that both IFN -a and IFN-y play an important role in influenza
virus stimulated NK cell IFN- y production. Next we wanted to explore the role o f major
cell types producing these cytokines. Plasmacytoid DC secrete significant amount o f
IFN-a in response to influenza stimulation (228). We decided to remove pDC from
resting PBMC from healthy young subjects by using BDCA4 micro-beads and examine
how reduction o f pDC influence NK cell activation in response to influenza virus by
performing FI assay.

BDCA4 is a cell adhesion molecule and known to be exclusively

expressed on pDC in resting PBMC. We found removal o f pDC from PBMC
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significantly down-regulated NK cell activation determined as the frequency o f
CD69+IFN-yf NK cells over total NK cells and adding removed pDC back to the pDCreduced PBMC tended to restore NK cell activation though the restoration did not reach
the significant level at o=0.05 (Figure 11 A, left). In fact, pDC dose-dependent increment
o f NK cell activation was observed, though the number o f subjects tested was limited
(Figure 11 A, right), supporting that pDC could be important in NK cell activation
regulation.

In addition to pDC we wanted to know how T cells influence NK cell activation for T
cell is the only cell type, in addition to NK cells to secrete significant amount o f IFN-y
upon activation. We decided to remove T cells from resting PBMC from healthy young
subjects by using CD3 micro-beads and examine how reduction o f T cells influence NK
cell activation in response to influenza virus by performing FI assay.

We could not find

significant difference in NK cell activation by influenza virus between PBMC and T cellreduced PBMC. This could be due to some non-specific o f the isolation procedure effect
on NK cells or other cells regulating NK activity. Instead o f this, when the removed T
cells were added back to the T cell-reduced PBMC, there was a T cell dose-dependent
increment in NK cell activation (Figure 1 IB), indicating T cells were playing a
significant role in mediating NK cell activation in response to influenza virus.

III.4 Aging Affected pDC and T Cell Frequencies and Cytokine Productions as well as
pDC-mediated NK Cell IFN-y Production

•

Plasmacytoid D C frequency in PBMC and ability to secrete IF N -a were downregulated in older subjects

In previous experiments we confirmed IFN -a was a critical mediator for NK cell
activation in response to influenza virus (Figures 7 and 8 ) and IFN -a levels were
significantly reduced in PBMC in response to influenza stimulation in older subjects
(Figure 6 A). IFN -a in PBMC in response to influenza virus was significantly contributed
by pDC therefore it was o f importance to know how aging influence pDC with respect to
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Figure 11. Effects of pDC or T cells on NK cell IFN - 7 production in response to influenza
virus in PBMC
A. Effect of pDC. One million PBMC or pDC-removed PBMC from 12 healthy young
subjects were stimulated with 1 /xl o f influenza virus with or without addition of isolated pDC.
Fastlmmune assay and flow cytometry was used to determine the frequency of CD 6 9 +IFN-7 +
NK cells. Left, effect of reducing pDC or adding pDC back to pDC-removed PBMC. Right,
pDC dose-dependent effect. One part of pDC dose was comparable to pDC amount isolated
from 1 million PBMC. B. Effect of T cells. Half million T-cell reduced PBMC from 4
healthy young subjects were stimulated with 1 jul of influenza virus with or without addition of
isolated T cells. Fastlmmune assay and flow cytometry was used to determine the frequency
of CD6 9 +IFN-7 + NK cells. One part of T cell dose was comparable to T cell amount isolated
from 1 million PBMC. Horizontal bars represent the median.
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its availability and function. To examine whether there was a difference in pDC
frequency in PBMC between young and older people, we performed live cell staining on
PBMC from 52 healthy young and 75 healthy older subjects. It was observed that the
frequency o f pDC in PBMC in older subjects was significantly lower than that in the
young subjects (p<0.05, Figure 12). The median o f pDC frequency in the young subjects
was 0.14%, which was in contrast to the median, 0.10%, in older people. The absolute
median value o f pDC frequency was 0.04% different between young and older subjects,
which reflected a 29% numerical deduction in the older subjects relative to the young.
Further, we wanted to examine whether there was an intrinsic functional defect in pDC
from older adults. We isolated pDC from pooled PBMC from young or older subjects,
stimulated them with influenza virus and monitored IFN -a secretion in supernatant by
ELISA. Significantly lower level o f IFN -a secretion was found in older subjects (2.915.6, median=7.6 ng/ml, 37.6+13.4% o f reduction, mean+SD) than that in the young
control (5.7-19.2, median=10.9 ng/ml, p<0.05, Figure 13). These results suggests that
down-regulation o f both the frequency and intrinsic function o f pDC leads to reduced
production o f IFN -a and contributes to N K cell activation down-regulation in response to
influenza virus in older people.

P < 0 .0 5

Young

Old

Figure 12. Comparison of frequency of pDC in PBMC between young and older people
Plasmacytoid DC frequency in PBMC between 52 healthy young and 75 healthy older adults
was compared. PBMC were co-stained with anti-lineage marker (FITC), CD123(PE), HLADR(PerCP) and CD1 lc(APC) antibodies and identified as cells characterized as
CD123+HLA-DR+ and lineage marker-CDl lc- by flow cytometry.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

47

P<0.05

V)

2 0 -|

t3
c

15 -

□
J3>
(A
C
Cti

♦
♦
■

10 5 -

m

a
a

■

Z

■

0 -

Young

Old

Figure 13. Plasmacytoid DC isolated from older subjects secreted less IFN-a upon influenza

infection
Plasmacytoid DC were isolated by using BDCA-4 magnetic beads from pooled PBMC of young
(2-6 donors per pool) or older (4-8 donors per pool) volunteers. Isolated pDC were infected with
1 /d of influenza virus in 96-well plate. Supernatant was collected the next day and examined for
IFN-a by ELISA. Data from 5 independent experiments involving 22 young and 30 older subjects
are shown. Elongated bars represent the median.

•

T cell frequency and function decrease with age

The age-related changes in T cell function have been one o f the major focuses in the field
o f immunology and aging. Data from our early research showed T cell, particularly
CD4+ and CD 8 + memory T cell responses to influenza infection and vaccination
declined in elderly people (174). This is consistent with our current data that NK cell
activation correlated with T cell activation and both were down-regulated with in older
people (Figure 1 and 2B, and II). Here we simply compared the quantities o f PBMC, T
cells and monocytes in human peripheral blood between 12 healthy young and 23 healthy
older subjects and observed PBMC yield, pan T cell, CD4+ T cell and CD 8 + T cell
quantities in blood were significantly lower in older subjects than those in the young
people (Table III). On the other hand, significant differences in numbers o f CD14+
monocytes between the two age groups was not detected (Table III).
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Table III. Comparison o f PBMC, T cell and monocyte numbers* in human peripheral
blood between young and older subjects
T cells

Monocytes

PBMC
(million/ml)

CD3+
(million/ml)

CD4+CD3+
(million/ml)

CD8+CD3+
(million/ml)

CD14+
(million/ml)

Young
(n=12)

1.25 + 0.43

0.84+0.30

0.57+0.21

0.23+0.076

0.059+0.047

Old
(n=23)

0.85 + 0.30

0.49+0.23

0.36+0.17

0.13+0.099

0.044+0.029

P value
(2-tail t- test)

0.003

0.0006

0.0038

0.0031

0.2693

P value (2-tail
Mann-Whitney
test)

<0.001

* PBMC number was calculated by dividing total amount of PBMC obtained after blood
processing by total volume of blood from which PBMC were isolated. CD3, CD4, CD8 positive
T cells or CD 14 positive monocyte numbers were caluculated by multiplying PBMC number by
frequency of each cell type in PBMC. The frequency of each cell type in PBMC was determined
by live cell staining of resting PBMC and flow cytometry.

•

Plasmacytoid D C from young subjects better facilitated N K cell activation than
pD C from older subjects in response to influenza virus

Previous experiments in this study suggested that pDC were important in activating NK
cells in response to influenza stimulation. We asked whether pDC from young or older
people differentially mediate NK cell activation by influenza virus. We performed FI
assay, in which equal amounts o f pDC isolated from PBMC pool from either young or
older subjects were added to individual PBMC followed by stimulation with influenza
virus. We found pDC isolated from young adults better functioned significantly than
pDC isolated from older subjects in stimulating NK cell activation in both young and
older subjects (p<0.05, Figure 12). The percent o f NK cells that were activated in the
presence o f young or aged pDC in the young subjects ranged from 0.4-5.2% with
median=2.1% and 0.4-4.9% with median=1.3%, respectively. Percent o f NK cells that
were activated in the presence o f young or aged pDC in the older subjects ranged from
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0.1-6.2% with m edian= l.l% and 0.03-2.8% with median=0.6%, respectively. We didn’t
observe an up-regulation o f NK cell activation when additional pDC, whether young or
aged were added to PBMC as compared to that without additional pDC. There was a
trend, though not having reached the significant level that NK cell activation was lower
in older subjects than that in the young when PBMC from young and older subjects were
treated the same way (Figure 14). It was surprising that the difference in NK cell
activation in influenza stimulated PBMC between young and older subjects was not as
significant as we observed before (Figure 5B). Beside differences due to donor variation
and experimental error, this could be a consequence o f smaller sample size and/or smaller
age difference between young and older subjects in current study than that in the previous
(43 subjects with age range o f 23-40 years, mean=29 years for the young and 65-81 years,
mean=74 years for the older in previous study compared with 17 subjects with age range
o f 21-44, mean=33 year for the young and 60-84 years, mean=69 years for the older
subjects in current study). In general, these results are consistent with what we have
observed in the earlier part o f this study, together indicating down-regulated pDC
function contributes to down-regulated NK cell activation in response to influenza virus
in older subjects.

III. 5 Soluble Factors vs. Cell-cell Contact in Regulating NK Cell IFN-y Production

•

N K cells were activated by soluble factors in the absence o f contact with other
cells

To investigate to what extent soluble factors vs. cell-cell contact participates in mediating
NK cell IFN-y production in response to influenza stimulation we first asked whether NK
cells were activated by soluble factors alone. To exclude the influence o f cellular contact,
we used supernatants generated from influenza virus -stim ulated PBMC to stimulate
autologous NK cells isolated from PBMC by using CD56 micro-beads.

As shown in

Figure 15, both CD69 intensity in NK cells and the frequency o f IFN-y producing NK
cells in the presence o f influenza virus-stimulated supernatant (9.3 to 16.6, median =11.7
for CD69 intensity, and 0.14-20%, median=4.5% for IFN-yf NK frequency) were
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significantly higher (p<0.05) than those in the presence o f non-stimulated supernatant
(6.0 to 8.0, median=7.1 for CD69 intensity, and 0-0.7%, median=0.08% for IFN -yf NK
frequency) or media control (5.7 to 7.7, median= 6 .8 for CD69 intensity, and 0.07-1.7%,
median=0.17% for IFN-7 + NK frequency, Figure 15A and B). This clearly indicated NK
cells were able to be activated by soluble factors only without cell-cell contact between
NK and other cells, particularly antigen presenting cells in PBMC in response to
influenza virus.
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Figure 14. Differential effects of pDC from young or older subjects on NK cell activation in
response to influenza virus
Plasmacytoid DC were isolated by using BDCA-4 magnetic beads from pooled PBMC from either
young (2-3 donors per pool) or older (2-3 donors per pool) volunteers. ). One a hundredth million
isolated pDC were co-cultured with 1 million individual PBMC in the presence of 1 /xl of influenza
virus in 96-well plate. FI assay and flow cytometry was used to determine the frequency of
activated NK cells. The graph represents data from 4 independent experiments involving 9 young
and 8 older subjects. Horizontal bars represent the median.

•

Cell-cell contact contributes to N K cell activation in response to influenza viral
stimulation

Results from Figure 13 suggested that NK cells are activated in the absence o f contact
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Figure 15. NK cell activation by supernatant generated from influenza virus-stimulated PBMC
One million PBMC were stimulated with 1 /xl of influenza virus as did in regular FI assay except
for no addition of BFA. Supernatant was collected the next day and used to stimulate NK cells
isolated by CD56 micro-beads without addition of influenza virus. Supernatant and NK cells
were donor-matched. A regular FI assay and flow cytometry was used to detect NK cell
activation manifested by IFN-y secretion in CD69+ cells. A, frequency o f CD69+IFN-y+ NK
cells. B, CD69 intensity in NK cells. Six healthy young subjects were recruited to this study.
Horizontal bars represent the median.

with other cells. On the other hand, in the environment o f PBMC, contact with other,
particularly antigen presenting cells may provide NK cell a better opportunity to be
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activated to a higher level than that by soluble factors alone. To examine whether
cellular contact plays a significant role in NK cell activation, we performed a transwell
experiment, in which isolated CD56+ NK cells were placed in transwells and prevented
from contact with CD56-removed PBMC placed in the regular well and stimulated with
influenza virus. Soluble factors can freely transport between the transwells and regular
wells through semi-permeable membranes. It was observed when cell-cell contact was
prevented, NK cell activation was significantly down-regulated, reflected by a reduction
in both the percentage o f CD69+IFN-y+ NK cells and CD69 intensity in overall NK cells
compared to the contact control (Figure 14). In contrast to 2-3.9% o f NK cells activated
by contact with CD56(-) PBMC, only 0.05-0.3% o f NK cells were activated without
contact (p<0.05). The intensity o f CD69 was 5.3-11.6 with contact and 4.8-9.2 without
contact (p<0.05). These results clearly indicated that cell-cell contact regulation is
playing a vital role in activating NK cells in response to influenza stimulation.

III. 6 Influences o f aging on expression o f receptor or ligand involved in cell-cell
recognition between NK cells and antigen presenting cells

•

Differential expressions ofN K p44 and NKp46 receptors on N K cells in PBMC
between young and older subjects

NK cells recognize and elicit cytotoxicity towards viral infected antigen presenting cells,
particularly monocytes via conventional and unconventional ways. The conventional
way involves interaction between NK inhibitory receptors and MHC I molecule on
monocytes and an unconventional way involves recognizing viral proteins, HA protein
for influenza virus, expressed on infected APC by NK activating receptors NKp44 and
NKp46. Since cell-cell contact significantly influences IFN-y production in NK cells in
PBMC in response to influenza virus (Figure 16), it is o f interest to examine how aging
influences the expression o f the activating receptors specifically recognizing influenza
HA protein. The expression pattern o f NKp44 and NKp46 was different in NK cells.
The former didn’t show distinct NKp44 positive or negative cell populations, therefore
was analyzed only the overall intensity on NK cells. The latter exhibited distinct NKp46

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

53
A.

B.
P<0.05

ID
£ *
£TS S
*
C
io a 1
O t;
U =
«4- A
0
o
Sz
3 +
O ' S3
O
□
L1

P<0.05
P<0.01

P<0.01

-ft■f110
s
03

5■

t
-frI

Influenza

+

+

Contact

+

+

Figure 16. Down-regulation of NK cell activation in response to influenza virus without cellular

contact
One million CD56-reduced PBMC were stimulated with 20 /xl of influenza virus. 0.2 million
CD56+ NK cells isolated from PBMC was placed in transwell or mixed with CD56-reduced PBMC
in regular well as the control. FI assay and flow cytometry was used to detect NK cell activation
manifested by IFN-y secretion in CD69+ cells. A, frequency of CD69+IFN-y+- NK cells. B, CD69
intensity in overall NK cells. Elongated bars represent the median.

positive or negative cell populations, therefore we analyzed both the intensity o f NKp46+
NK cells and the frequency o f NKp46+ cells in total NK cell populations. We observed
that both the NKp44 and NKp46 expression were significantly increased by influenza
viral stimulation, reflected by the increased intensity o f NKp44 and NKp46 in both age
groups (p<0.05, 0.01 or 0.001, Figure 17A) but not the frequency o f NKp46+ NK cells,
although the frequency o f NKp46+ NK cells increased in both mock-stimulated and
influenza virus-stimulated PBMC as compared to resting PBMC (Figure 17B). The
values o f the measurements are listed in Table IV. Opposite to that lower frequency o f
IFN-y producing NK cell frequency was detected in the elderly than young subjects,
higher intensity o f NKp44 on resting NK, media (mock)-stimulated NK and influenzastimulated NK cells (Figure 17A, upper plot) and higher frequency NKp46+ NK cells
after influenza stimulation (Figure 17B, lower plot) were found in the older subjects than
the young subjects. Considering older people possessed higher frequency o f total NK
cells in lymphocytes than young subjects (S. Figure 1), it was not surprising that the
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frequency o f NKp46+ NK cells in lymphocytes, whether under resting, mock-stimulated
or influenza-stimulated conditions, was higher in the older subjects than that in the young
(Figure 17B). These results indicated that NKp44 and NKp46 might not be the
contributing factors for down-regulated NK cell activation with respect to IFN - 7
production in older people, but a valid conclusion can not be drawn unless functional
studies show that aging does not affect the functions o f these receptors.

•

Differential expression o f influenza HA protein on monocytes in influenza virus
infected PBMC between young and older subjects

NKp44 and NKp46 recognize influenza HA protein expressed on monocytes. We
wonder whether there is differential expression o f HA on monocytes between young and
older subjects upon influenza viral infection. As expected, HA expression on CD 14
monocytes was significantly elevated in response to influenza infection as compared to
the mock (media) infection in both young and older subjects (Figure 18A, left) with HA
intensity ranging from 43-55 (median=49) and 50-104 (median=69) for mock-stimulation
and influenza-stimulation, respectively, in the young subjects and 36-65 (median=52) and
54-114 (median= 6 6 ) for mock- and influenza-stimulation, respectively, in the older
subjects. Consistently, CD69 expression on the monocytes was increased from 13.1-26.8
(median=18.8) to 19.4-48.6 (median=25.7) after influenza viral stimulation in the young
subjects and from 13.9-26.5(median=18.4) to 22.2-50.6 (median=36.5) after influenza
viral stimulation in the older subjects, confirming monocytes were activated by influenza
virus. However, we could not detect differences in either the absolute values o f HA
intensity, CD69 expression on monocytes (Figure 18A) or the fold increase in them in
response to influenza viral infection (Figure 18B) between young and older subjects.
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Figure 17. Comparison of NKp44 and NKp46 expression between young and older subjects
Resting, media (mock)-activated or influenza-activated PBMC from 12 healthy young and 24 healthy
older subjects were measured by live cell staining and flow cytometry for NKp44 and NKp46
expression. The stimulation procedure followed regular FI culture set-up procedures except for using
2/d of influenza virus and adding no BFA. The cells were cultured for 18— 20 hours before being
stained. A, intensity of NKp44 (top) or NKp46 (bottom). B, Frequency of NKp46+ NK cells in
overall NK cells (top) or in overall lymphocytes (bottom). Horizontal bars represent the mean.
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Figure 17 (cont.)- Comparison of NKp44 and NKp46 expression between young and older subjects
Resting, media (mock)-activated or influenza-activated PBMC from 12 healthy young and 24 healthy
older subjects were measured by live cell staining and flow cytometry for NKp44 and NKp46
expression. The stimulation procedure followed regular FI culture set-up procedures except for using
2/d of influenza virus and adding no BFA. The cells were cultured for 18—20 hours before being
stained. A, intensity of NKp44 (top) or NKp46 (bottom). B, Frequency of NKp46+ NK cells in
overall NK cells (top) or in overall lymphocytes (bottom). Horizontal bars represent the mean.
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Table IV. Expressions o f NKp44 and NKp46 on NK cells in PBMC *

Intensitv of NKd44
Activation
Status
resting
PBMC
mediastimualted
influenza
virusstimulated

Intensitv of NKd46

NKp46+ NK% in
NK

NKp46+ NK% in
inlvmohocvtes

young

old

young

old

young

old

young

old

8.1(1.6)

10.6(3.1)

99(26)

100(34)

70(13)

71(13)

10(5.6)

14(6.7)

8.5(1.5)

11.6(3.1)

124(24)

127(32)

74(12)

71(15)

14(7.9)

20(7.8)

16.6(4.4)

21.0(7.3)

130(29)

144(34)

66(14)

70(13)

13(8.3)

19(7.4)

* Values are expressed in the format o f mean (s.d.).

III. 7 Examination on Monocyte-mediated NK Cell Activation in Response to Influenza
Virus

•

Comparison in frequency o f monocytes between young and older subjects

Monocytes play an important role in cell-cell contact regulation o f NK cell
activation(229). We wanted to know whether the frequency o f monocytes in PBMC was
different between young and older subjects. As indicated in Table III, there was no
significant difference in the frequency o f CD 14+ monocytes between the two age groups,
indicating the aging effect on monocyte-mediated NK cell activation, if any, was not a
result from age-related numerical deduction o f monocyte.

•

Examination o f monocyte-mediated N K cell activation in young and older adults

Monocytes regulate NK cell activation via secreting cytokines and cell-cell contact
mechanism in response to influenza virus; therefore this interaction can be a potential
contributor for NK cell activation down-regulation in older people. It is o f interest to
know how monoyctes isolated from young or older people differentially mediate NK cell
activation in response to influenza virus. We performed FI assays, in which equal
amounts o f CD 14+ monocytes generated by pooling equal amount o f monocytes isolated
from individual donors in young or older subjects were added to moncyte-depleted,
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Figure 18. Comparison of influenza HA and CD69 expression on monocytes between young and

older subjects
Media (mock)- or influenza-activated PBMC from 12 healthy young and 24 healthy older subjects
were measured by live cell staining and flow cytometry for HA and CD69 expression on Cdl4+
monocytes. Regular FI culture set-up procedures were followed except for not having BFA added into
the culture. One ju.1 of influenza virus was used for infection. The cells were cultured for 14-16 hours
before staining was initiated. A, intensity of HA (left) or CD69 (right). B, fold of increase in HA and
CD69 intensity upon influenza stimulation. Horizontal bars represent the median.

namely Mono(-) PBMC and infected by influenza virus. We could not detect a
significant difference in NK cell activation in Mono(-) PBMC from either young or old
subjects between addition o f non-aged (young) monocytes and aged (older) monocytes
(Figure 19), although there was a trend o f lower NK cell activation in older subjects
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between addition o f two kinds o f monocytes (p=0.08, Figure 19). The percent o f NK
cells that were activated in the presence o f young and aged monocytes in the young
subjects ranged from 0.8-18.2% with median=10.1% and 0.6-24.3% with median=4.2%,
respectively. Percent o f NK cells that were activated in the presence o f young or aged
monocytes in the older subjects ranged from 0.5-11.7% with median=2.6% and 0.2-6.7%
with median=l .2%. We didn’t observed an up-regulation o f N K cell activation when
additional monocytes, whether young or aged were added to Mono(-) PBMC as
compared to that without additional monocytes. There was a trend, though not having
reached the significant level that NK cell activation was lower in older subjects than that
in the young when Mono(-) PBMC from young and older subjects were treated the same
way (Figure 19). There seemed to be an influenza-unrelated activation due to monocyte
isolation procedure in influenza virus-stimulated Mono(-) PBMC for NK cell activation
was significantly elevated in Mono(-) PBMC, regardless the age groups, compared to that
in the untouched PBMC (Figure 17). From these data, we could not draw a conclusion
on how monocytes from young and older subjects differentially mediated N K cell
activation while it seemed the difference between young and aged monocyte in activating
N K cells with lower activation by aged monocytes was more obvious in older Mono(-),
PBMC than that in young Mono(-) PBMC. Whether this is a valid conclusion remains to
be further investigated.

III. 8 Summary o f Results

•

Specific Aim 1

1. NK cell activation measured as the frequency o f CD69+IFN-y+ NK cells as well as the
intensity o f IFN-y in CD69+IFN-y+ N K cells in response to influenza viral stimulation in
PBMC is reduced in older subjects as compared to the young subjects.

2. Down-regulated NK cell activation correlated with down-regulated IFN-o: level and T
cell activation in response to influenza viral stimulation in PBMC in older subjects as
compared to the young subjects.
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Figure 19. Effect of monocytes from young or older subjects on NK cell activation in response

to influenza virus
Monocytes were isolated by using CD 14 magnetic beads from individual PBMC and pooled for
either young (2-3 donors per pool) or aged (2-3 donors per pool) monocytes for study. One a
hundredth million isolated pDC were co-cultured with 1 million individual PBMC in the
presence of 1 fil of influenza virus in 96-well plate. Fastlmmune assay and flow cytometry was
used to determine the frequency of activated NK cells. The graph represents data from 4
independent experiments involving 9 young and 8 older subjects. Elongated bars represent
the median.

3. Both IFN-a! and IFN-y play positive roles in stimulating NK cells to produce IFN-y in
response to influenza virus as demonstrated by effects o f neutralizing antibodies against
IFN-c^IFN-a/jS receptor or effects o f rlFN-Y

4. Plasmacytoid DC and T cells play a positive role in stimulating NK IFN-y production
as demonstrated by pDC-depletion assays.

5. Lower frequencies o f pDC and CD3+ T cells in PBMC were observed in older subjects.
Lower levels o f IFN -a secreted by purified pDC and lower frequency o f IFN-Y-producing
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CD3+ T cells in PBMC in response to influenza vims were detected in older subjects
than young subjects.

6.

Plasmacytoid DC isolated from young subjects better facilitated NK cell activation

than pDC isolated from older subjects in response to influenza viral stimulation in
PBMC.

•

Specific Aim 2

1. Supernatants generated from influenza vims-activated PBMC in the absence o f cell
cell contact stimulated NK cells to produce IFN-y. Preventing NK cell contact with other
cells by transwell significantly down-regulates NK cell to produce IFN-y

2. Expression o f NK cell activating receptors NKp44 and NKp46 on NK cells in PBMC
were elevated in response to influenza stimulation in both young and older subjects.
Surprisingly, expression levels o f both receptors were higher in older subjects than that in
the young whether PBMC were at resting, mock-stimulated or influenza-stimulated status.

3. No significant difference in expression levels o f influenza HA on monocytes upon
influenza infection was observed between young and older subjects.

4. No significant difference in frequency o f monocytes in PBMC was observed between
young and older subjects. Monocytes isolated from young subjects tended to better
facilitate NK cell activation than monocytes isolated from older subjects in response to
influenza vims in older subjects.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

62

IV. DISCUSSION AND CONCLUSIONS

IV. 1 Down-regulated Natural Killer (NK) Cell Activation in Response to Influenza Virus
in Older Subjects

Influenza is a disease associated with high mortality and morbidity in elderly population
(2-4). Natural killer (NK) cells play a critical role in controlling viral load at early stages
o f immune defense by eliciting cytotoxicity and secreting cytokines, particularly IFN- y
(82). NK cells respond to influenza infection and vaccination (85, 155, 156). Our study
demonstrates a significant aging-related down-regulation o f IFN - 7 production by NK
cells in response to influenza virus (Figure 5).

The aging-related impairment in NK cell EFN- 7 production is manifested by a lower
frequency o f CD69+IFN-y+- NK cells (Figure 3B) in influenza virus-infected PBMC from
the elderly subjects than that from the young subjects. The frequencies o f CD69+IFN-y+
NK cells were calculated in both total NK cells and total lymphocytes. The frequencies
calculated using these two different denominators were highly correlated with the
correlation coefficients o f 0.90, 0.74 and 0.85 in the young, elderly and combined groups,
respectively. We deem the necessity o f calculating CD69+IFN-yf NK frequencies in
both total NK cells and total lymphocytes lies in two aspects. First, NK cells are
phenotypically and functionally heterogeneous with CD56dimCD16bnght subset primarily
executing cytotoxicity and secreting small amount o f IFN-7 , and CD56bnghtCD16dim
subset being the primary IFN-y-secreting cells (82, 84). Using total NK cell number as
the denominator can not guarantee the age-related decline in the frequency o f
CD69+IFN-7+ NK cells is due to the decline o f the IFN-y-producing NK cell number but
not the increase o f the non-IFN-y-producing NK cell number. In fact, an age-related
increase in peripheral NK cell number has been found in both CD56dimCD16bngbt and
CD56bnghtCD16dlmNK subsets with higher increased number o f CD16bnght cells than
CD56bnght cells ( 8 6 , 230, 231). Unfortunately, we were not able to differentiate these two
subsets in our experiment due to the same fluorescent shared by CD 16 and CD56
antibodies. Second, ignoring N K subsets, the age-related increase in the number o f total
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N K cells bears the potential to balance the age-related decrease in the frequency o f IFN-y
+ NK cells calculated in total NK cells. Calculating the frequencies o f IFN-y -producing
NK cells in total lymphocytes becomes necessary in determining whether lower
proportion o f IFN-y+- NK cells in total NK cells can be a fair reflection o f less IFN-y producing NK cells in peripheral blood in elderly subjects than young subjects. As
shown in Figure 5B, whether total NK cell number or total lymphocyte number was used
as the denominator, the frequency o f CD69+IFN-y+ NK cells in response to influenza
stimulation is lower in the elderly subjects than that in the young subjects, suggesting the
lower frequency o f CD69+IFN-y+ NK cells results from the reduction in the number o f
NK subsets that are capable o f producing IFN-y.

In addition to numerical decline, the aging-related impairment o f NK cell IFN- y
production in response to influenza virus was reflected by the significantly lower IFN- y
intensity in NK cells in the elderly subjects than that in the young subjects (Figure 5C).
The lower IFN-y intensity indicates NK cells, as a heterogeneous entity in PBMC, are
functionally impaired in IFN-y production in response to influenza virus in the elderly
subjects compared to the young. It should be noted that this lower IFN-y intensity can be
a consequence o f the reduced IFN-y production in NK cells in a per-cell basis and/or the
relative increase in the proportion o f CD16hlgh over CD56hlgh cells in the total IFN -y+
NK cells with no change in the per-cell based IFN-y production in a single N K cell.
Thus, no conclusion regarding truly functional impairment in per-cell based IFN-y
production in NK cells in the elderly subjects compared to the young can be drawn
without differentiating CD56hlgh versus CD16h,gh NK cell subsets, though NK cell as a
whole does display aging-related functional defect in IFN-y production. The agingrelated down-regulation o f IFN-y production by NK cells in response to influenza virus is
not related to the impairment in signal transduction during the early stage o f NK
activation for no significant difference in the frequency or intensity o f CD69+ NK cells
has been detected between young and elderly subjects. This suggests early signal
transduction during NK cell activation in PBMC in response to influenza infection is
likely well preserved with advanced aging.
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In summary, our data demonstrates the significantly down-regulated human NK cell IFNy production in PBMC from elderly subjects compared to young subjects in response to
influenza infection. This aging-related down-regulation o f IFN-y production in NK cells
is manifested by the reduction in the frequencies o f CD69+IFN-y + NK cells in total NK
cells as well as in total lymphocytes, and in the amount o f IFN-y produced by total NK
cells, but not in the early signal transduction reflected by CD69 expression. NK cell
activation involves three activities: proliferation, cytotoxicity, cytokine, particularly IFNy production (230). Evidence has shown that purified NK cells from the elderly subjects
proliferate to the less extent responsive to IL-2 than NK cells from the young subjects
while the IL-2 levels in response to influenza virus have been shown to be lowered with
advanced aging under many, if not all experimental conditions (171, 172, 175, 230). NK
cytotoxicity is also known to be affected by aging. Thus, age-related changes have been
detected in all three facets o f NK activation in response to influenza virus, suggesting NK
cells could be one o f the major targets o f the aging process that contributes to the agerelated impairment in immune defense against influenza.

IV.2 IFN-o, pDC and Down-regulated NK Cell IFN-y Production in Response to
Influenza Virus in Older Subjects

IF N -ais a family o f cytokines comprising 13 different functional subtypes (232, 233).
IFN- a have been recognized as a pro-Thl cytokine that stimulates NK and T cell
cytotoxicity and IFN-y production synergistically with IL-18 (216, 234). In addition,
type I interferons including IFN -a and IFN-/3, have been considered important in
enhancing humoral immunity, particularly by providing the help for plasma cell
differentiation (199, 235, 236). NK cell IFN-y production in response to influenza virus
has been shown down-regulated in the elderly subjects compared to the young subjects in
earlier session o f our study (Figure 5). How important IFN-a is involved in influenzainduced NK cell IFN-y production in the aging context has not been addressed previously.
Our data have suggested IFN- q: is a significant contributor participating in the agingrelated down-regulation o f NK cell IFN-y production in response to influenza virus by
providing the following evidences.
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First, in the presence o f IFN -a or IFN-a//3 receptor neutralizing antibodies, the frequency
o f IFN - 7 producing NK cells considerably decreased compared to the control, indicating
IFN-a is a significant mediator for NK cell IFN - 7 production in influenza virusstimulated PBMC (Figure 7). The importance o f IFN -a in this scenario is further verified
by the use o f CpG ODN2216, and the depletion o f pDC, one o f the major sources o f IFNa in PBMC (237). The CpG is known to specifically induce IFN -a production in pDC
though activating TLR-9 (238). Our data has verified that CpG ODN2216 specifically
induces IFN -a production in CD123high (pDC) cells but not CD1231ow (monocytes)
cells (Figure 8 A). The frequency o f IFN-7 -producing NK cells in influenza-stimulated
PBMC increases in parallel with the elevated IFN -a production in the presence o f the
CpG ODN2116 while decreases by pDC depletion (Figure 8 B and 11 A), confirming the
regulatory role o f IFN -a in stimulating NK IFN - 7 production in response to influenza
virus. We have realized that the inhibitory effect o f pDC depletion on NK IFN - 7
production is not as strong as the neutralization o f IFN -a or its receptors, and replacing
the depleted pDC back to the culture only created a trend but not the significant level o f
restoration o f the frequency o f IFN-7 -producing NK cells (Figure 7 and 8 A). This is
likely due to the effect o f IFN -a produced by the remaining monocytes and possibly pDC
in PBMC after pDC depletion. We have also tried to examine the effect o f rIFN -a on NK
IFN - 7 production in a dose dependent manner but have not detected any effect. This is
unlikely due to the mismatched IFN -a subtype used in our experiment because IFN-02,
the subtype we used is known to be a functioning subtype in PBMC in response to
influenza virus and was detected by IFN-a2 specific antibody in our assays (ref, Figure
8 A).

Possible reasons could be that endogenous IFN -a level had been saturated before

rEFN-a was added and/or there needs another soluble factor working in conjunction with
IFN-a2 to optimize the effect.

Second, we have found IFN -a level in the supernatant o f activated PBMC is significantly
reduced in the elderly subjects compared to the young subjects in response to influenza
viral stimulation, which coincides with the lower frequency o f IFN-7 -producing N K cells
described earlier (Figure 6 A and 5). The correlation between IFN -a level and the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

66

frequency o f IFN-7 -producing NK cells from these samples is moderate (r=0.56) but
statistically significant (p<0.05, Table II). Moreover, we have found about 30%
reduction in the average frequency o f pDC in PBMC and 38+13.4% (mean+SD)
reduction in the amount o f IFN -a produced by purified pDC stimulated with influenza
virus in the elderly subjects compared to the young subjects, suggesting that both
numerical and functional impairments are present in pDC in response to influenza
infection in the elderly. Figure 14 further suggests the existence o f intrinsic defects in
pDC in older subjects by showing higher frequency o f IFN-y+ NK cells in the presence
o f pDC isolated from the young subjects than those isolated from the older subjects in
response to the influenza virus infection. That pDC secrete higher amount o f IFN -a than
monocyte in a per-cell basis while IFN-a+ cell number are comparable between CD123hi
(manifest o f pDC) and CD1231ow (majority monocytes) cells (data not shown) suggests
that pDC is more productive in IFN -a generation than monocytes in response to influenza
infection. Considering the significant role o f IFN -a in activating NK cells, it is not
surprising that the aging-associated impairments in pDC will significantly contribute to
the down-regulation o f NK IFN - 7 production in response to influenza virus in the elderly
subjects.

IV.3 IFN-y, T cells and Down-regulated NK Cell Activation in Response to Influenza
Virus in Older Subjects

In addition to its role as an effector cytokine, IFN-y plays a regulatory role in mediating
T hl immune response, promoting NK cell differentiation and influencing antibody
production (176, 184). IFN-y is secreted by CD4+ type I helper T cells, CD 8 + cytotoxic
T cells and NK cells in response to influenza infection (174, 239). Our preliminary
kinetic study on CD69 expression in PBMC suggests that T cell activation precedes NK
cell activation in response to influenza virus, generating the possibility that IFN-y
produced by T cells influences NK cell IFN-y production in response to influenza virus
(S. Figure 3).
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The role o f IFN-y in regulating NK IFN - 7 production specifically in response to influenza
virus is verified in our study. First, our data indicates a trend that the frequency o f IFN-y
-producing NK cells declines in the presence o f neutralizing antibodies against IFN-y,
though the decline does not reach significant level (Figure 9). In fact, the trend o f the
decline is obvious in the subjects with higher baseline levels o f IFN-y+ NK cell
frequency than those w ith relatively lower baseline levels (Figure 9), indicating the
responsiveness to the neutralizing antibody may require certain baseline limit. Second
and more importantly, in response to influenza virus purified (CD56+ and/or CD 16+) NK
cells can not be activated to produce IFN-y in the presence o f monocytes unless rIFN-y is
added, indicating the importance o f pre-existing IFN-y in inducing NK cell IFN-y
production (Figure 10). Moreover, purified NK cells can not be activated to produce
IFN-y in the presence o f combination o f influenza virus and rIFN-y (data not shown),
indicating IFN-y mediates NK cell activation via acting on monocytes. He and
Romagnani have reported previously that the production o f IFN-y in CD56bright NK
cells is mediated by CD3+ or CD4+ T cells in an IL-2-dependent manner (159, 222).
Monocytes are not known to be a source o f IL-2 but IL-15, a cytokine that share
similarity with IL-2 and capable to activate NK cells via a NK-monocyte contactdependent mechanism (240, 241). It will be o f interest to see whether IFN-y is able to
induce IL-15 secretion in monocytes and further mediate NK IFN-y production in
response to influenza virus. Last, we have tried to deplete CD3+ T cells from PBMC but
have not found the difference in NK cell IFN-y production between CD3+ T cell-depleted
and non-depleted PBMC. Interestingly, when isolated T cells were added back to the
CD3(-) PBMC, there exhibits a T cell amount-dependent increase in NK IFN-y
production in response to influenza stimulation (Figure 11B), supporting the role o f T
cells in positively influencing NK IFN-y production. We think the unresponsiveness o f
NK IFN-y production to CD3+ T cell depletion might be due to the non-specific
activation in T(-) PBMC caused by the isolation procedure.

Taken together, our data suggest a positive role o f existing IFN-y on NK cell EFN-y
production prior to N K activation. The source o f the earlier generated IFN-y is likely the
activated memory T cells. Importantly, down-regulation o f IFN-y production in CD4+
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T hl and CD8+ cytotoxic T cells in response to influenza infection and vaccination with
advanced aging has been documented (81, 174, 188, 242). Consistent with the literature,
our data shows that IFN-y production determined as the frequency o f IFN-y + CD3+ T
cells in PBMC stimulated with influenza virus is reduced and correlates with the
decreased frequency o f IFN-y-producing N K cells in the elderly subjects compared to the
young subjects (Figure 5B, 6B and II). Along with the decreased IFN -yf T cell
frequency, a lower frequency o f total peripheral T cells is found in the elderly subjects
than in the young subjects (Table III), indicating both numerical and functional
impairment o f IFN-y producing T cells is associated with aging in response to influenza
virus. Considering the significant role o f IFN-y in mediating NK cell IFN-y production,
we believe the age-associated down-regulation o f T cell IFN-y production contribute to
down-regulated NK cell IFN-y production in older people in response to influenza virus.

IV.4 Cell-cell Contact Regulation in NK Cell Activation in Response to Influenza Virus
in an Aging Context

Cell-cell contact between NK cells and antigen presenting cells, particularly dendritic
cells and monocytes has been suggested a required condition for different aspects o f NK
cell activation (229). For instance, in human ex vivo experiments, preventing the contact
between monocytes or monocyte-derived mDC can reduce NK cell IFN-y secretion,
cytotoxicity and CD69 expression and preventing the contact between pDC and NK cells
can lower CD69 expression on NK cells without affecting NK IFN-y secretion and
cytotoxicity in response to influenza virus (194, 239). Consistent with these findings, our
data shows a significant reduction in both the frequency o f IFN-y+ N K cells and the
CD69 intensity in N K cells in response to influenza virus when cell-cell contact between
N K cells and NK(-) PBMC is prevented compared to when the contact remains available
(Figure 16). On the other hand, our data shows purified CD56high NK cells can be
activated by supernatant generated from influenza-stimulated PBMC without the
presence o f contacting with other cell types, suggesting cellular contact between NK cells
and antigen presenting cells (APC) may not be an essential condition, but possibly
required for the optimal level o f NK cell activation (Figure 15 and 16).
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The mechanism o f cellular contact between NK cells and APC to mediate NK activation
could lie in the reciprocal interactions between NK cells and APC, that is, cellular contact
is required for full activation o f APC and conversely fully activated APC secrete optimal
levels o f cytokines to promote NK activation (194). NK receptors or other molecular
elements that participate in this cell-cell contact regulation are not clear yet. But
evidence has shown that NK natural cytotoxic receptors (NCR) NKp44 and NKp46
specifically recognize influenza HA and sendai virus hemaglutinin-neuraminidase (HN),
both viruses inducing cytokine as well as NK- monocyte-derived macrophages contactdependent NK cell activations (229). NKp44 and NKp46 are known to be exclusively
expressed on NK cells and mediate NK cytotoxicity (202, 217). Our data shows that
influenza virus enhances the expressions o f these two receptors on NK cells (Figure 17A
and B). Without knowing the role o f these receptors in mediating NK cell IFN - 7
secretion, we started with examining how aging influences the expressions o f the
receptors by comparing their expression levels on NK cells before and after influenza
stimulation between the young and the older subjects. Our data shows whether at resting,
mock- or influenza-stimulated status, NKp44 intensity is higher in the older subjects than
that in the young (Figure 17A). NKp46 intensity level is comparable between the young
and the old subjects independent o f the treatments while the frequency o f NKp46+ NK
cells in lymphocytes is significantly higher in the older subjects than that in the young,
leading to a numerical increase in NKp46+ NK cells with advanced aging (Figure 17A
and B). The higher frequency or expression level o f NKp44 and NKp46 on NK cells
from the elderly subjects than the young subjects can hardly explain the aging-related
impairment in NK cell IFN-y production in response to the influenza virus. But there are
a few possibilities that might help understand this contradiction. First, a frequency
change does not always positively correlates with a functional change. We did not
perform functional analysis on the NCR receptors, therefore that the receptor-positive NK
cell frequency increases as a compensatory mechanism in response to the declined
function o f the receptors remains possible. Second, the time when the measurements (1214 hours post viral stimulation) were done may not be the optimal time point to detect the
difference in the receptor expression between the two age groups. It is reported that

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

70
influenza vims infects and the viral replication continues for 4-6 hours before being
halted in human peripheral monocytes (243). It is possible that the lower receptor
intensity in the NK cells from the young subjects than those from the older subjects at the
time o f the detection results from the kinetic difference in the receptor expression
between the young and the elderly subjects, or more specifically is caused by the earlier
declining o f the elevated receptor expression on the surface o f NK cells in response to
influenza vims in the young subjects than in the older subjects. Future studies addressing
these possibilities may help clarify the observation.

To examine whether monocytes from young or older people function differentially in
stimulating NK cell to produce IFN-y in response to influenza, we have examined NK
cells in monocyte-depleted PBMC with restoration o f monocytes isolated from either the
young or the elderly subjects. Unfortunately, we could not detect the significant
differences in NK cell IFN-y production between young and old monocyte-mediated
conditions in either the young or the elderly group (Figure 19). In spite o f this, there was
a trend that the young monocytes facilitate a better NK cell activation than the aged
monocytes, particularly for the older subjects (Figure 19). Increasing sample size in
future studies might help generate more significant data and better delineate the role o f
monocytes in regulating NK cell activation in an aging context.

It is interesting that in the transwell experiment when CD56+ NK cell was in transwell
and CD56(-) PBMC were in the regular well, not only the IFN-y production o f NK cells
in the transwell was down-regulated but also that o f the T cells in the regular well (data
not shown). This is consistent with our previous observation that NK cell activation
highly correlates with T cell activation in PBMC in response to influenza stimulation
(Figure 4 and Table II). A simple explanation would be that preventing cell-cell contact
down regulate NK cell IFN-y production, which in turn affect monocyte activation and
consequently lead to down-regulated T cell activation. If this was true, a reciprocal
regulation between NK cell and T cell activations by IFN-y autocrine/paracrine
asecretions could be established through the link o f monocytes.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

71
In summary, cell-cell contact regulation between NK cells and APC, particularly
moncytes, monocyte-derived mDC and macrophages have been suggested as an
important part o f the requirements for optimal NK cell activation. Our data has
confirmed that both cell-cell contact between NK cells and APC and soluble factors play
a significant role in inducing NK cell IFN - 7 production. How cell-cell contact functions
alone and cooperates with soluble factors to activate NK cells remains to be elusive.

IV. 5 Potential Roles o f Other Soluble Factors in Aging-related Down-regulation o f NK
Cell IFN-y Production in Elderly Subjects in Response to Influenza Virus

Our study has suggested that aging-related reduction in pDC IFN-o; and T cell IFN-y
productions contribute to the impairment in NK cell IFN-y production in PBMC in
response to influenza virus for the elderly adults. The fact that no significant NK cell
IFN-y production was detected when isolated CD56+NK cells were stimulated with IFNa alone, IFN-y alone, influenza alone or any combination o f the three stimuli (data not
shown) indicates other factors are required for inducing the NK cell activity in response
to influenza. Correlation analysis in the combined young and elderly subjects reveals
moderate correlations between the supernatant IFN -a level and the frequency o f IFN-y producing NK cells (r=0.56), and weak correlation between the IFN -a level and the
frequency o f IFN-y-producing T cells (r=0.35), further supporting that multiple factors
are involved in NK and T cell activation in PBMC and weaken the linear relationship
between the supernatant IFN -a level and the frequencies o f IFN-yF NK or T cells (Table
II).

Besides IFN -a and IFN-y, other soluble factors that potentially display the age-related
changes and able to influence NK IFN-y production in an aging context include, but are
not restricted to IFN-/3, IL-18, TN F-a and IL-2 (74, 234). IFN-/3 is one o f the major type
I IFNs that shares the similarities with IFN-a in antiviral effect and inducing NK cells
and T cells to produce IFN-y (232). IL-18 is known to be able to induce NK and T cell
cytotoxicity and IFN-y production synergistically with IFN-a//3, IL-12 and/or TNF-a,
among which, IL-12 is not known to be significantly produced in human PBMC in
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response to influenza vim s (48,157,193, 244,245). Our previous data has shown
PBMC from elderly subjects secrete lower level o f TN F-a in supernatant than young
subjects at 3 hours but not 18 hours post influenza A stimulation, indicating a potential
role o f TN F-a at early stage o f immune reactions in contributing to the age-related NK
activation down-regulation (174). Surprisingly, in the same study no significant
difference in IL-2 level between young and old subjects were detected, indicating IL-2
level may not be necessarily an essential factor for the age-related impairment o f NK
IFN-y production in our experimental system, although IL-2 levels have been shown to
be down-regulated with advanced aging in response to influenza stimulation under many
other conditions (118,119, 172, 175, 225, 246). Information about the age-related
changes in the productions o f IFN-b and IL-18 are very limited up to date, therefore their
contribution to NK activation including IFN-y production in the aging context remains
unclear.

In addition to external factors, internal defects o f NK cells with aging should be taken
into consideration when comparisons in NK activation are made between different age
groups. Literatures have shown that purified peripheral NK cells from elderly subjects
display lower CD69 expression and proliferation ability in response to IL-2 than those
from young subjects, indicating intrinsic impairment in NK cells do exist with advanced
aging (230). On the other hand, studies on the expressions o f cytokine receptors on NK
cells have not suggested a difference in IL-2 receptor expression whether on resting or
IL-2-stimulated NK cells between young and elderly subjects(247). Moreover, Plett and
others even reports that higher level o f IFN-oZ/3 receptors with comparable IFNoh/receptor binding activity is found on NK cells from aged mice than young mice. But
this elevated IFN-aZ/S receptor expression in the aged mice may be associated with
enhanced apoptosis o f NK cells induced by IFN-a. Apparently more studies are needed
for obtaining a clear picture o f how NK cell functions are influenced by aging. Future
investigations on both the intrinsic and extrinsic factors related to NK activation will
provide more valuable insights into the aging-related changes on NK cell activation in
responses to influenza virus.
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IV. 6 Conclusions

In this study we have compared IFN - 7 production in NK cells in influenza virusstimulated PBMC between young and elderly subjects and investigated soluble factors,
particularly IFN -a and IFN-y, and cell-cell contact between NK cells and other cells in
PBMC in mediating the NK cell IFN-y production in 311 aging context. Based on our data,
we conclude:

1. Interferon-alpha (IFN-a) and IFN-y are important regulatory cytokines in stimulating
NK cells to produce IFN-y in PBMC in response to influenza virus. Aging-related
numerical and functional impairments in pDC and T cells lead to the reduced production
o f IFN-a and IFN-y, which contribute to the down-regulated NK cell IFN-y production in
the elderly subjects compared to the young subjects.

2. Cell-cell contact regulation between NK cells and APC in PBMC may be important in
activating NK cells to the full extent in conjunction with soluble factors in response to
influenza virus. How cell-cell contact regulates NK cell activation and what age-related
differences in components involved in the cell-cell contact regulation contribute to the
impaired NK cell activation in older people remain to be elucidated.

IV.7 Significance o f the Study

Immune senescence leads to increased mortality and morbidity and decreased vaccine
efficacy associated with influenza with advanced aging. As a critical component o f the
innate immune system, NK cells play an important role in defending viral infection by
eliciting cytotoxicity and secreting IFN- 7 . Our study has focused on delineating the
aging-related changes in NK cell IFN-y production in response to influenza virus and
revealing potential causal factors for these changes. We have concluded that IFN -a and
IFN-y are important mediators for influenza-induced NK cell IFN-y production, and
aging-related impairments in IFN -a production by pDC and IFN-y production by T cells
contribute to the down-regulated NK cell IFN-y production in the elderly subjects
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compared to the young subjects. We have also suggested that the cell-cell contact
between NK cells and monocytes is important in activating NK cells to produce IFN-y to
the full extent. To our knowledge, this is the first systemic investigation about the aging
effect on NK cell IFN-y production in response to influenza virus. Our data supports that
NK activity can be one o f the major targets o f the aging process that leads to the immune
dysfunction in the elderly people in response to influenza virus.

The significance o f NK cells in influenza-induced immune response extends from the
innate immunity to the adaptive immunity via the production o f IFN-y, the manifest
cytokine o f T hl lymphocytes by NK cells. Previous studies have suggested T hl but not
Th2 lymphocytes prevent lethal dose o f influenza virus or promote the recovery in
normal or aging-accelerated mice, and T hl but not antibody response correlates with the
outcome o f influenza vaccination in human (174, 189, 248,249). These evidences
suggest that T hl immunity is an important part o f anti-influenza immune responses. Our
earlier work has shown an age-related impairment in IFN-y production in influenzaspecific CD4+ T hl cells and cytotoxic T cells in older adults. Since T cells and NK cells
are the predominant source o f IFN-y, our current study completes the picture that the
deficiency o f IFN-y production in elderly adults in response to influenza virus is
attributed not only to the T cells but also to the NK cells. Moreover, our study has
confirmed the importance o f IFN -a and IFN-y in mediating NK IFN-y production
specifically to influenza virus and pointed out that the aging-related impairments in the
productions o f these interferons by pDC and CD3+ T cells contribute to the aging-related
down-regulations in NK cell IFN-y production. Therefore, our study has provided
valuable information on how T hl immune response is impaired in the elderly people in
response to influenza virus.

NK cell activities, particularly cytotoxicity have been documented to be responsive to
influenza vaccination with live-attenuated, inactivated trivalent split vaccines or
inactivated viral particles in human, indicating NK cells are significantly involved in
vaccination-induced defending mechanism against influenza (155, 156, 223). However,
information about NK cell IFN-y production in response to influenza vaccine is very
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limited if not completely missing. We deem monitoring NK cell IFN - 7 production
should be as equivalently important as monitoring NK cytotoxcicity for a vaccination
study. Although not directly related to a vaccine study our finding is valuable to be used
as a reference at the starting point for a comparative influenza vaccine study between
young and elderly subjects.

Our study utilizes human blood as the experimental material, therefore bypasses the
possible discrepancies in information translation o f the findings from animals to human.
It’s our strong belief that our findings will bring valuable insights on how aging
influences innate immune system and T hl immunity and help establish the fundamentals
for developing more effective prophylactic and therapeutic approaches for elderly people.

IV. 8 Restrictions o f the Study

Similar to many other studies, our study is restricted in certain ways. First, influenza is a
localized but not systemic infection (1). Using influenza-stimulated PBMC is a mimic o f
a systemic infection. However, this restriction is hard to be avoided due to the limited
tissue types to be obtained from human subjects. Second, we did not consider the
survival factors for the elderly subjects in our study. Aging is commonly associated with
a survival issue. If the selection pressure for the survival is unrelated to the variable to be
investigated, survival factor will not be important. Otherwise, it will be affecting the
validity o f the age-related change because the “change” could be a simply “unchanged”
fact that is survived from other age-related mortality. Unfortunately, in most occasions it
is hardly to know whether the selection pressure for the survival is related to the variable
to be investigated or not. Longitudinal study, which is more cost-inefficient, would be a
solution to avoid the influence o f the survival factor. Third, it is common in human
studies that sample availability restricts sample size, duplication possibility, repeating
possibility. These restrictions may increase the chance o f getting data with bigger
variations and un-conclusive results.
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IV .9 Future Directions

We would like to continue to investigate soluble factors in influenza-induced Thl
immunity in an aging context. We would differentiate subgroups o f NK cells,
particularly differing CD56high versus CD561ow cells so that the aging-related absolute
and relative increase o f the frequencies o f IFN- 7 -producing NK subsets and decrease in
the per-cell-based IFN-y intensity will be clarified. Further more, questions as what is the
mechanism by which cell-cell contact regulates NK cell activation; how relatively
important pDC versus monocytes are in producing IFN-a; which subtypes o f IFN -a are
important; whether IFN-b participates in aging-related changes in immune regulation;
how IFN -a contributes to the impaired T cell activation in the elderly; how IFN-y
influences monocytes and consequently influences NK cell activation; and how NK cells
influence T cell function in response to influenza virus would be o f great interest to be
investigated.

We would also like to investigate the relationship between Thl response and antibody
response in influenza-induced immunity. Generating protective antibody is one o f the
primary goals o f the vaccination. Knowing how cytokines influence antibody production
in young and elderly subjects in response to influenza infection and vaccination will be o f
great value for providing the fundamentals for developing more effective prophylactic
and therapeutic approaches for human.

Lastly, we would like to evaluate the potential o f IL-12 family o f cytokines in enhancing
influenza-induced human T hl immunity in the elderly subjects. Interleukin 12 (IL-12)
and IL-23 are not produced in human PBMC stimulated with influenza while exogenous
IL-12 significantly enhances IFN-y production in human PBMC either alone or
synergistically with influenza virus (48, 49, and data not shown). Whether IL-12 family
o f cytokines can be developed into an adjuvant for influenza vaccines in the elderly
people is o f interest to be evaluated.
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VI. APPENDICES
VI. 1 Supplemented Figures (S. Figures)
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S. Figure 1. Frequencies o f total NK cells in total lymphocytes in young and elderly
subjects.
One million PBMC from each of 15 healthy young and 25 healthy older subjects were stained for
CD56+orl6+CD3- NK cells and NK cell frequencies were determined by flow cytometry.
Columns represent the mean and error bars represent the standard deviation.
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S. Figure 2. Expression o f CD69 on NK cells in PBMC from young and elderly subjects.
One million PBMC from each of 15 healthy young and 25 healthy older subjects were stimulated
with 1 jtil of influenza virus in 96-well plate overnight. Fastlmmune assay and flow cytometry
was used to determine the expression of CD69 and IFN-y in NK cells. A, CD56+orl6+ NK cells
were gated out of lymphocytes and analyzed for CD69 intensity on CD69+IFN-y+ or CD69+DFNy- NK cells by flow cytometry. Columns represent the mean and error bars represent the standard
deviation. B, comparison of CD69+IFN-y- NK cell frequency in total NK cells between young
and older subjects. Columns represent the mean and error bars represent the standard deviation.
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S. Figure 3. Sequential activation o f monocytes, T cells and NK cells in PBMC in
response to influenza infection
One million PBMC from each of 3 healthy young subjects were stimulated with 1 /d of influenza
virus in 96-well plate overnight followed by staining with anti-human CD3(FITC),
CD56/16(PE), CD69 (PerCP) and CD14 (APC) antibodies. Frequencies o f CD69expressing cells in each cell type were determined by flow cytometry. The percent o f
completion o f activation determined as the ratio o f frequency o f CD69+ cells at each time
point over the frequency o f CD69+ cells at 21-hour time point are shown.
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